HTTP 200 OK
Allow: GET, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"count": 1453,
"next": "https://mitotox.org/api/compounds/list?format=api&page=13",
"previous": "https://mitotox.org/api/compounds/list?format=api&page=11",
"results": [
{
"compound_ID": "D1128",
"name": "toluidine blue",
"synonyms": "Toluidine Blue; Toluidine Blue O; TOLONIUM CHLORIDE; Basic Blue 17; 92-31-9; Blutene chloride; Blutene; Gabilin; Menodin; Tolazul; Klot; C.I. Basic Blue 17; Toloni chloridum; F Klot; Toluidine Blue OO; Toluidene Blue O Chloride; Toluidinblau; Dimethyltoluthionine chloride; Schultz no. 1041; Tolonii chloridum; Cloruro de tolonio; Chlorure de tolonium; Schultz 1041; Toluidinblau [German]; Tolonium chloride [INN]; C.I. 925; Modr Toluidinova [Czech]; Toluidine Blue (phenothiazine dye); Modr Zasadita 17 [Czech]; UNII-15XUH0X66N; CCRIS 4933; Tolonii chloridum [INN-Latin]; Cloruro de tolonio [INN-Spanish]; Chlorure de tolonium [INN-French]; Dimethyltoluthionine chloride (VAN); EINECS 202-146-2; 3-Amino-7-(dimethylamino)-2-(methylphenazathionium) chloride; NSC 11225; 15XUH0X66N; CHEBI:87647; Phenothiazin-5-ium, 3-amino-7-(dimethylamino)-2-methyl-, chloride; NSC-11225; NSC-36758; Toluidine Blue O, pure; Phenazathionium, 3-amino-7-(dimethylamino)-2-methyl-, chloride; T-3922; 3-Amino-7-dimethylamino-2-methylphenazathionium; DSSTox_CID_28654; DSSTox_RID_82924; DSSTox_GSID_48728; MLS000738130; Modr Toluidinova; Phenothiazin-5-ium, 3-amino-7-(dimethylamino)-2-methyl-, chloride (1:1); CAS-92-31-9; Modr Zasadita 17; NSC11225; C.I. 52040; NCGC00181775-01; (7-amino-8-methylphenothiazin-3-ylidene)dimethylamine, chloride; (7-amino-8-methylbenzo[3,4-b]benzo[e]1,4-thiazin-3-yl)dimethylamine, chloride; Toluidine Blue 00; Toluidine Blue O, 80%; Toluidine Blue O, 85%; n-(7-amino-8-methyl-3h-phenothiazin-3-ylidene)-n-methylmethanaminium chloride; C.I.BASIC BLUE 17; SCHEMBL122592; SCHEMBL338335; CHEMBL562639; CHEMBL1790006; DTXSID9048728; C15H18N3S; Toluidine Blue, phenothiazine dye; GEDVVYWLPUPJJZ-UHFFFAOYSA-N; HNONEKILPDHFOL-UHFFFAOYSA-M; 3-amino-7-(dimethylamino)-2-methylphenothiazin-5-ium chloride; HMS1545F05; HMS2752P23; HMS3264B13; Pharmakon1600-01506191; Toluidine Blue O, Technical grade; NSC36758; Toluidine Blue (C.I. 50240); Tox21_113159; NSC760421; SBB057635; SBB059304; AKOS015916405; AKOS024282653; Tox21_113159_1; CCG-213755; MCULE-6445743179; NSC-760421; NCGC00181775-02; CI-52040; ST057360; LS-105696; FT-0690009; FT-0724562; ST51006740; X6800; Q80868; SR-01000760899; WLN: T C666 BN ISJ E1 FZ LN1&1 &G; SR-01000760899-2; Toluidine Blue O, certified by the Biological Stain Commission;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C15H16ClN3S",
"molecular_weight": "305.8",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "7083",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02158",
"RC02779",
"RC03400"
]
},
{
"compound_ID": "D1129",
"name": "tolvaptan",
"synonyms": "Tolvaptan; 150683-30-0; Samsca; OPC-41061; OPC 41061; N-(4-(7-Chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-benzo[b]azepine-1-carbonyl)-3-methylphenyl)-2-methylbenzamide; N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide; Tolvaptan (OPC-41061); CHEMBL344159; NCGC00183001-01; AK-33401; C26H25ClN2O3; Benzamide, N-(4-((7-chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl)-3-methylphenyl)-2-methyl-; benzazepine derivative, 32; Tolvaptan [USAN:INN:BAN]; HSDB 8196; Benzamide, N-[4-[(7-chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methyl-; 7-Chloro-5-hydroxy-1-(2-methyl-4-(2-methylbenzoylamino)benzoyl)2,3,4,5-tetrahydro-1H-1-benzazepine; tolvaptan-opc-41061; Samsca;OPC-41061; DSSTox_CID_28706; DSSTox_RID_82975; DSSTox_GSID_48780; SCHEMBL242421; GTPL2226; DTXSID3048780; BDBM35723; CHEBI:32246; CTK8B8272; OPC-41061(TOLVAPTAN); GYHCTFXIZSNGJT-UHFFFAOYSA-N; HMS3604L08; HMS3656K20; HMS3744A09; N-[4-[(7-Chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methylbenzamide; Tox21_113256; ANW-59865; CT0200; PDSP1_001738; PDSP2_001721; s2593; AKOS015994735; Tolvaptan, >=98% (HPLC), powder; API0024498; CS-0572; KS-1315; 4CA-1265; AC-22748; HY-17000; ZINC000000538658; AB0009995; AB2000685; AX8158397; TC-148610; AM20090726; CAS-150683-30-0; FT-0645839; ST24031322; SW219182-1; AB01565822_02; 683T300; L001628; Q426132; SR-01000942265; SR-01000942265-1; (+-)-4'-((7-Chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl) carbonyl)-o-tolu-m-toluidide; (+-)-4'-((7-Chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl)-o-tolu-m-toluidide; 5-hydroxy-7-chloro-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1h-benzazepine; 7-chloro-5-hydroxy-1-[2-methyl-4-(2-methyl benzoyl amino) benzoyl]-2,3,4,5-tetrahydro-1H-1-benzazepine; 7-chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoylamino) benzoyl]-2,3,4,5-tetrahydro-1H-1-benzazepine; 7-chloro-5-hydroxy-1-[2-methyl-4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-1-benzazepine; N-(4-(7-Chloro-5-hydroxy-2,3,4,5-tetrahydro-1H-benzo[b]-azepine-1-carbonyl)-3-methylphenyl)-2-methylbenzamide; N-[4-(7-Chloro-5-hydroxy-2,3,4,5-tetrahydro-benzo[b]azepine-1-carbonyl)-3-methyl-phenyl]-2-methyl-benzamide; N-[4-(7-chloro-5-hydroxy2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide; N-[4-(9-chloro-6-hydroxy-2-azabicyclo[5.4.0]undeca-8,10,12-triene-2-carbonyl)-3-methyl-phenyl]-2-methyl-benzamide;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C26H25ClN2O3",
"molecular_weight": "448.9",
"state": "solid",
"clearance": "4 mL/min/kg (post-oral dosing).",
"volume_of_distribution": "Healthy subjects: 3L/kg; slightly higher in heart failure patients.",
"route_of_elimination": "Fecal- very little renal elimination (<1% is excreted unchanged in the urine)",
"protein_binding": "99% bound",
"half_life": "Terminal half life, oral dose = 12 hours.",
"absorption": "Tmax, Healthy subjects: 2 - 4 hours;\nCmax, Healthy subjects, 30 mg: 374 ng/mL;\nCmax, Healthy subjects, 90 mg: 418 ng/mL;\nCmax, heart failure patients, 30 mg: 460 ng/mL;\nCmax, heart failure patients, 90 mg: 723 ng/mL;\nAUC(0-24 hours), 60 mg: 3.71 μg·h/mL;\nAUC(∞), 60 mg: 4.55 μg·h/mL;\nThe pharmacokinetic properties of tolvaptan are stereospecific, with a steady-state ratio of the S-(-) to the R-(+) enantiomer of about 3. The absolute bioavailability of tolvaptan is unknown. At least 40% of the dose is absorbed as tolvaptan or metabolites. Food does not impact the bioavailability of tolvaptan.",
"cid": "216237",
"classification": "C",
"indications": "",
"side_effects": "",
"atc_codes": "C03XA01",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02159",
"RC02780",
"RC03401"
]
},
{
"compound_ID": "D1130",
"name": "transfluthrin",
"synonyms": "Transfluthrin; 118712-89-3; UNII-QWL3SKA6EG; QWL3SKA6EG; CHEBI:32253; (2,3,5,6-tetrafluorophenyl)methyl (1R,3S)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate; (2,3,5,6-Tetrafluorophenyl)methyl(1R,3S)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate; 2,3,5,6-tetrafluorobenzyl (1R,3S)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate; Transfluthrin [ISO]; NCGC00181025-01; Transfluthrin (JAN); DSSTox_CID_26812; DSSTox_RID_81924; DSSTox_GSID_46812; SCHEMBL26844; Cyclopropanecarboxylic acid, 3-(2,2-dichloroethenyl)-2,2-dimethyl-, (2,3,5,6-tetrafluorophenyl)methyl ester, (1R,3S)-; CHEMBL3184657; DTXSID4046812; DDVNRFNDOPPVQJ-HQJQHLMTSA-N; ZINC5455493; Tox21_112675; AKOS015899270; DB15117; Transfluthrin 10 microg/mL in Cyclohexane; CAS-118712-89-3; CS-0110699; C13410; D01932; K-1327; Transfluthrin, PESTANAL(R), analytical standard; 712T893; Q418421; 2,3,5,6-tetrafluorobenzyl (1r)-trans-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate; 2,3,5,6-Tetrafluorobenzyl (1R,3S)-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropane-1-carboxylate; 2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropane- carboxylate;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C15H12Cl2F4O2",
"molecular_weight": "371.2",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "656612",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02160",
"RC02781",
"RC03402"
]
},
{
"compound_ID": "D1131",
"name": "tribenoside",
"synonyms": "tribenoside; 10310-32-4; TBGF; Ethyl 3,5,6-tri-O-benzyl-D-glucofuranoside; (3R,4R,5R)-4-(Benzyloxy)-5-((R)-1,2-bis(benzyloxy)ethyl)-2-ethoxytetrahydrofuran-3-ol; Tribenzoside; Glyvenal; Glyvenol; D-Glucofuranoside, ethyl 3,5,6-tris-O-(phenylmethyl)-; Glivenol; 21401-BA; Tribenosidum [INN-Latin]; Tribenosido [INN-Spanish]; Tribenosido; Tribenosidum; C29H34O6; EINECS 233-687-2; Ba 21401; BG-356; Ethyl-3,5,6-tri-O-benzyl-D-glucofuranoside; D-Glucofuranoside, ethyl-3,5,6-tris-o-(phenylmethyl)-; Tribenoside [USAN:INN:BAN:JAN]; Glucofuranoside, ethyl-3,5,6-tri-o-benzyl-, D-; Prestwick3_001019; BSPBio_001177; BPBio1_001295; SCHEMBL7192326; CHEMBL3301681; CHEBI:91780; Ethyl 3,5,6-tri-O-benzyl-D-glucofuranoside;Ethyl 3,5,6-tri-O-benzyl-D-glucofuranoside; HMS2098K19; HMS3715K19; AKOS022185031; API0004490; CCG-221019; DB13227; NCGC00179274-01; AK117679; AB00514005; FT-0660910; ST24034462; 310T324; Q533119; SR-01000872695; SR-01000872695-1; W-200685; BRD-A60294240-001-01-1; (3R,4R,5R)-5-[(1R)-1,2-bis(phenylmethoxy)ethyl]-2-ethoxy-4-phenylmethoxy-3-oxolanol;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C29H34O6",
"molecular_weight": "478.6",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "196122",
"classification": "C",
"indications": "",
"side_effects": "",
"atc_codes": "C05CX01; C05AX05",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02161",
"RC02782",
"RC03403"
]
},
{
"compound_ID": "D1132",
"name": "tribromosalan",
"synonyms": "Tribromsalan; 3,5,4'-Tribromosalicylanilide; Agramed; 87-10-5; 3,5-Dibromo-N-(4-bromophenyl)-2-hydroxybenzamide; TRIBROMOSALICYLANILIDE; Tribromsalanum; Trisanil; Trisanyl; 3,4',5-Tribromosalicylanilide; Tempasept II; Temasept II; Temasept IV; Sherstat TBS; Vancide TBS; Tuasol 100; Tribromosalicyanilide; Tribromosalan; ET-394; Stecker asc-4; TBS 95; Polybrominated salicylanilide; ASC-4; Caswell No. 863; Tribromsalen; Tuasol; TBS; 3,5-Dibromosalicylic acid p-bromoanilide; UNII-6MCE3VTF0O; Tribromsalanum [INN-Latin]; NSC-20526; CCRIS 5745; Tribromsalan [USAN:INN:BAN]; Tuasal 100; WR 34912; CHEBI:127105; Salicylanilide, 3,4',5-tribromo-; Salicylanilide, tribromo-; EINECS 201-723-6; BENZAMIDE, 3,5-DIBROMO-N-(4-BROMOPHENYL)-2-HYDROXY-; ENT 25516; 6MCE3VTF0O; EPA Pesticide Chemical Code 077404; BRN 2146888; 3,5-Dibromo-N-(4-bromo-phenyl)-2-hydroxy-benzamide; AI3-25516; KVSKGMLNBAPGKH-UHFFFAOYSA-N; Tribromosalicylanilide, 3,4',5-; NCGC00159476-02; DSSTox_CID_6181; DSSTox_RID_78049; DSSTox_GSID_26181; 3,5-dibromo-N-(4-bromophenyl)-2-hydroxy-benzamide; CAS-87-10-5; C13H8Br3NO2; Diaphene; Tuasal; Hilomid (Salt/Mix); Diaphene (Salt/Mix); Lamar L-300; Tuasol 100 (TN); Tribromsalan (USAN/INN); 3,5-Tribromosalicylanilide; Epitope ID:114087; Oprea1_401911; MLS004773969; 3,4',5-Tribromosalicylanide; CHEMBL24944; SCHEMBL121315; ACMC-20977w; Salicylanilide,4',5-tribromo-; WLN: QR BE DE FVMR DE; DTXSID4026181; KVSKGMLNBAPGKH-UHFFFAOYSA-; BDBM234329; ZINC538492; NSC20526; Tox21_111700; Tox21_202442; Tox21_303223; ANW-13626; NSC 20526; STK301503; AKOS003291727; Tox21_111700_1; LS-1862; MCULE-9233062723; NCGC00159476-03; NCGC00159476-04; NCGC00159476-05; NCGC00159476-06; NCGC00159476-09; NCGC00257186-01; NCGC00259991-01; SMR001551623; LS-144203; TC-102370; FT-0614129; FT-0621967; ST45025671; D06218; Benzamide,5-dibromo-N-(4-bromophenyl)-2-hydroxy-; Q27219423; 3,5-Dibromo-N-(4-bromophenyl)-2-hydroxybenzamide (31); (3,5-dibromo-2-hydroxyphenyl)-N-(4-bromophenyl)carboxamide; 3,5-Tribromosalicylanide and 4,5-dibromosalicylanide mixtures; 12738-72-6; InChI=1/C13H8Br3NO2/c14-7-1-3-9(4-2-7)17-13(19)10-5-8(15)6-11(16)12(10)18/h1-6,18H,(H,17,19);",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C13H8Br3NO2",
"molecular_weight": "449.92",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "14868",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02162",
"RC02783",
"RC03404"
]
},
{
"compound_ID": "D1133",
"name": "tributyltetradecylphosphonium chloride",
"synonyms": "81741-28-8; Tributyl(tetradecyl)phosphonium chloride; Tributyltetradecylphosphonium chloride; (Tri-n-Butyl)-n-Tetradecylphosphonium Chloride; Phosphonium, tributyltetradecyl-, chloride; Tributyl tetradecyl phosphonium chloride; Tri-N-butyl tetradecyl phosphonium chloride; UNII-82832Q4G52; 82832Q4G52; DSSTox_CID_14997; DSSTox_RID_79234; DSSTox_GSID_34997; W-111555; Caswell No. 866A; CAS-81741-28-8; EINECS 279-808-2; Tetradecyltributylphosphonium chloride; EPA Pesticide Chemical Code 128824; Tri-N-butyltetradecylphosphonium chloride; SCHEMBL358875; CHEMBL3183454; DTXSID9034997; CTK3E8857; KS-000000ZH; Tox21_202009; Tox21_303556; AKOS015833154; RTR-025657; TRA0043101; tributyl(tetradecyl)phosphanium;chloride; NCGC00257372-01; NCGC00259558-01; AK163584; TR-025657; FT-0688175; ST24050250; Q27269315; F0001-2100;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C26H56ClP",
"molecular_weight": "435.1",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "9889168",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02163",
"RC02784",
"RC03405"
]
},
{
"compound_ID": "D1134",
"name": "tributyltin benzoate",
"synonyms": "TRIBUTYLTIN BENZOATE; Tributylstannyl benzoate; Biomet 11; 4342-36-3; Tri-n-butyltin benzoate; Benzoyloxytributylstannane; Tris(n-butyl)tin benzoate; Tin, (benzoyloxy)tributyl-; Stannane, benzoyloxytributyl-; Caswell No. 867AA; Stannane, (benzoyloxy)tributyl-; Tin, tributyl-, benzoate; Tri-n-butyl-zinn benzoate; tri-n-butylbenzoyloxytin; Benzoic acid, tributylstannyl ester; Tri-n-butyl-zinn benzoate [German]; EINECS 224-399-8; EPA Pesticide Chemical Code 083106; NSC 221308; Tin, benzoate; Tributyltin benzoate, 98%; DSSTox_CID_14981; DSSTox_RID_79233; DSSTox_GSID_34981; DTXSID5034981; WLN: 4-SN-4&4&OVR; Tin, (benzoyloxy)tributyl- (7CI); Tox21_303395; NSC221308; ZINC170172514; NSC-221308; KS-0000265S; NCGC00164179-01; NCGC00164179-02; NCGC00164179-03; NCGC00257290-01; CAS-4342-36-3; LS-146427; C-55984; Q27275993;",
"trade_name": "",
"abbrev_name": "",
"description": "organotin compound ( organic compounds that contain tin); inhibit ATP synthase",
"molecular_formula": "C19H32O2Sn",
"molecular_weight": "411.2",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "16682834",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02164",
"RC02785",
"RC03406"
]
},
{
"compound_ID": "D1135",
"name": "tributyltin chloride",
"synonyms": "Tributyltin chloride; 1461-22-9; Chlorotributyltin; Tri-N-butyltin chloride; Stannane, tributylchloro-; Tributylchlorotin; Tributyl(chloro)stannane; TRIBUTYLCHLOROSTANNANE; Chlorotri-n-butyltin; Tri-n-butylchlorotin; Chlorotributylstannane; Tributylstannyl chloride; Stannane, chlorotributyl-; Monochlorotributyltin; Tin, tri-n-butyl-, chloride; Tributylstannium chloride; Chlorid tri-N-butylcinicity; Caswell No. 867A; Tri-n-butylzinn-chlorid; UNII-CA82T4QR5F; NSC 22323; Tributyl tinchloride; WR 3396; CCRIS 6319; HSDB 6816; Tri-N-butylzinn-chlorid [German]; Tri-n-butyl tin chloride; Chlorid tri-N-butylcinicity [Czech]; EINECS 215-958-7; EPA Pesticide Chemical Code 083107; CA82T4QR5F; GCTFWCDSFPMHHS-UHFFFAOYSA-M; NSC22323; DSSTox_CID_7403; DSSTox_RID_78441; DSSTox_GSID_27403; Tri-n-butyltin chloride, 95%, tech.; CAS-1461-22-9; C12H27ClSn; TRIBUTYL TIN CHLORIDE; tributyltinchloride; nBu3SnCl; Bu3SnCl; SnBu3Cl; n-Bu3SnCl; TBTC; tributylstannylchloride; chloro tri-n-butyltin; tri-n-butyltinchloride; Tributylchloro stannane; (Bu)3SnCl; tributyl tin chloride;; (n-Bu)3SnCl; Tri-butyl tin chloride; Tri-butyl-tin-chloride; Chloride tri-n-butyltin; ACMC-209cwc; tri-n-butyl-tin chloride; tri-n-butylstannylchloride; chloro-tri-n-butylstannane; tributyl tin(IV) chloride; tributyl(chloranyl)stannane; Tri(n-butyl) tin chloride; tri-n-butylstannyl chloride; EC 215-958-7; Tributyltin chloride, 96%; tri-Normal-butyltin chloride; TRI-BUTYLTIN CHLORIDE; TBTC (Tributyltin chloride); KSC491C2H; DTXSID3027403; CHEBI:79734; CTK3J1123; KS-00000VVC; WLN: G-SN-4&4&4; EBD40962; Tox21_201626; Tox21_300543; ANW-20986; MFCD00000521; NSC-22323; AKOS009031150; ZINC169743020; RTR-005779; TRA0084100; NCGC00164186-01; NCGC00164186-02; NCGC00164186-03; NCGC00254242-01; NCGC00259175-01; Tributyltin chloride, analytical standard; NCI60_001841; TBTC, PESTANAL(R), analytical standard; LS-146483; TR-005779; FT-0657606; X6216; Ac-DEVD-AFC (CAS 201608-14-2); C15224; A808453; Q-201893; Q2452578; Tri-n-butyltin Chloride 1000 microg/mL in Methanol; BRD-K88145757-001-01-6; F0001-0521; TBTC (Tributyltin chloride) 10 microg/mL in Isooctane;",
"trade_name": "",
"abbrev_name": "",
"description": "organotin compound ( organic compounds that contain tin); inhibit ATP synthase",
"molecular_formula": "C12H27ClSn",
"molecular_weight": "325.5",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "15096",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T019011"
],
"function": [
"F0108",
"F020103"
],
"references": [
"RC01195",
"RC01196",
"RC01197",
"RC01198",
"RC01199",
"RC02165",
"RC02786",
"RC03407"
]
},
{
"compound_ID": "D1136",
"name": "tributyltin methacrylate",
"synonyms": "Tributyltin methacrylate; Tri-n-butylstannylmethacrylate; Tin tributylmethacrylate; Tributylstannyl methacrylate; 2155-70-6; Tributyl(methacryloxy)stannane; Tributyl(methacryloyloxy)stannane; Caswell No. 867EF; UNII-BQ3J70T6UN; BQ3J70T6UN; STANNANE, TRIBUTYL(METHACRYLOYLOXY)-; HSDB 7310; ((Methacryloyl)oxy)tributylstannane; EINECS 218-452-4; EPA Pesticide Chemical Code 083120; NSC 221239; Stannane, ((methacryloyl)oxy)tributyl-; Tributyl((2-methyl-1-oxo-2-propenyl)oxy)stannane; 2-Propenoic acid, 2-methyl-, tributylstannyl ester; Stannane, tributyl((2-methyl-1-oxo-2-propenyl)oxy)-; [(Methacryloyl)oxy]tributylstannane; Stannane, [(methacryloyl)oxy]tributyl-; Stannane, tributyl[(2-methyl-1-oxo-2-propenyl)oxy]-; DSSTox_CID_15204; DSSTox_RID_79247; DSSTox_GSID_35204; Tributylmethacryloyloxystannane; SCHEMBL1026963; (Methacryloyloxy)tributylstannane; DTXSID9035204; Tox21_300409; NSC221239; ZINC195996212; NSC-221239; WLN: 4-SN-4&4&OVY1&U1; NCGC00248022-01; NCGC00254380-01; CAS-2155-70-6; LS-146623; Q27274810;",
"trade_name": "",
"abbrev_name": "",
"description": "organotin compound ( organic compounds that contain tin); inhibit ATP synthase",
"molecular_formula": "C16H32O2Sn",
"molecular_weight": "375.1",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "16682828",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02166",
"RC02787",
"RC03408"
]
},
{
"compound_ID": "D1137",
"name": "tricirbine",
"synonyms": "Triciribine; 35943-35-2; Pentaazacentopthylene; Tricyclic nucleoside; NSC 154020; Triciribine [INN]; API-2; Tricirbine; TCN; Triciribinum [INN-Latin]; Triciribina [INN-Spanish]; UNII-2421HMY9N6; BRN 1171593; C13H16N6O4; NSC-154020; 1,5-Dihydro-5-methyl-1-beta-D-ribofuranosyl-1,4,5,6,8-pentaazaacenaphthylen-3-amine; CHEBI:65310; 2421HMY9N6; 1,4,5,6,8-Pentaazaacenaphthylen-3-amine, 1,5-dihydro-5-methyl-1-beta-D-ribofuranosyl-; 1,4,5,6,8-Pentaazaacenaphthylene, 3-amino-1,5-dihydro-5-methyl-1-beta-D-ribofuranosyl-; 3-Amino-1,5-dihydro-5-methyl-1-beta-D-ribofuranosyl-1,4,5,6,8-pentaazaacenaphthylene; DSSTox_CID_25743; DSSTox_RID_81088; DSSTox_GSID_45743; Triciribina; Triciribinum; 5-methyl-1-(beta-D-ribofuranosyl)-1,5-dihydro-1,4,5,6,8-pentaazaacenaphthylen-3-amine; (2R,3R,4S,5R)-2-(3-amino-5-methyl-1,4,5,6,8-pentaazaacenaphthylen-1(5H)-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol; CAS-35943-35-2; 6-ARPPP; Akt/PKB Signaling Inhibitor-2; CHEMBL331237; Inhibitor V; NCGC00092314-01; NCGC00092314-04; API-2;Triciribine; Triciribine/API-2; NSC 154120; BiomolKI2_000078; SCHEMBL61268; MLS006011145; DTXSID6045743; CTK8F0953; AOB5912; EX-A415; BCPP000034; HMS3413I03; HMS3677I03; ZINC3808299; Tox21_111192; 2082AH; 2765AH; ABP000410; BDBM50369528; MFCD16879015; s1117; API-2;NSC 154020;TCN; AKOS024456958; Tox21_111192_1; CCG-100678; CS-0968; DB12405; SB14594; 1,4,5,6,8-Pentaazaacennaphthylen-3-amine, 1,5-dihydro-5-methyl-1-.beta.-D-ribofuranosyl-; 3-amino-1,5-dihydro-5-methyl-I-beta-D-ribofuranosyl-1,4,5,6,8- pentaazaacenaphthylene; 6-amino-4-methyl-8-(beta-D-ribofuranosyl)-(4H,8H)pyrrolo(4,3,2-de)pyrimido(4,5-c)pyridazine; NCGC00092314-02; NCGC00092314-06; 4CA-1279; HY-15457; SMR002530325; SRI-10809-03; LS-101390; TX-018033; FT-0639291; W-5227; 943T352; BRD-K80431395-001-01-6; BRD-K80431395-001-09-9; Q25326616; 1,4,5,6,8-Pentaazaacennaphthylen-3-amine, 1,5-dihydro-5-methyl-1-beta-D-ribofuranosyl-; 1,5-Dihydro-5-methyl-1-?-D-ribofuranosyl-1,4,5,6,8-pentaazaacenaphthylen-3-amine; 1,5-Dihydro-5-methyl-1-beta-D-ribofuranosyl-1,4,5,6,8pentaazaacenaphthylen-3-amine; 1,4,5,6,8-Pentaazaacennaphthylen-3-amine, 1,5-dihydro-5-methyl-1-beta-D-ribofuranosyl- (9CI);",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C13H16N6O4",
"molecular_weight": "320.3",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "65399",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02167",
"RC02788",
"RC03409"
]
},
{
"compound_ID": "D1138",
"name": "triclabendazole",
"synonyms": "Triclabendazole; 68786-66-3; Fasinex; 6-Chloro-5-(2,3-dichlorophenoxy)-2-(methylthio)-1H-benzo[d]imidazole; C14H9Cl3N2OS; Triclabendazol [INN-Spanish]; Triclabendazolum [INN-Latin]; CCRIS 8988; UNII-4784C8E03O; CGA 89317; 5-Chloro-6-(2,3-dichlorophenoxy)-2-(methylthio)-1H-benzimidazole; NVP-EGA230; CPD000466357; EGA230B; MLS001424101; CHEMBL1086440; 6-Chloro-5-(2,3-dichlorophenoxy)-2-methylthio-benzimidazole; 6-chloro-5-(2,3-dichlorophenoxy)-2-methylsulfanyl-1H-benzimidazole; CGA89317; CGA-89317; 4784C8E03O; NCGC00164610-01; Triclabendazole, 98%; AK-68238; SMR000466357; 5-Chloro-6-(2,3-dichlorophenoxy)-2-(methylthio)benzimidazole; 6-chloro-5-(2,3-dichlorophenoxy)-2-(methylthio)-1H-benzimidazole; 1H-BENZIMIDAZOLE, 5-CHLORO-6-(2,3-DICHLOROPHENOXY)-2-(METHYLTHIO)-; Triclabendazol; Egaten; Triclabendazolum; 5-[2,3-bis(chloranyl)phenoxy]-6-chloranyl-2-methylsulfanyl-1H-benzimidazole; Triclabendazole [BAN:INN]; 5-chloro-6-(2,3-dichlorophenoxy)-2-methylsulfanyl-1H-benzimidazole; Fasinex (TN); Egaten (TN); DSSTox_CID_23952; DSSTox_RID_80094; DSSTox_GSID_43952; Oprea1_236106; Triclabendazole (USAN/INN); cid_50248; MLS000759473; MLS000876812; SCHEMBL165712; BEN631; DTXSID7043952; BDBM58491; CHEBI:94759; CTK5C8452; KS-00000KPE; NQPDXQQQCQDHHW-UHFFFAOYSA-N; Triclabendazole [USAN:INN:BAN]; 6-chloro-5-(2,3-dichlorophenoxy)-2-methylthiobenzimidazole; HMS2051E16; HMS2232D14; HMS3370H02; HMS3393E16; HMS3652M16; HMS3715P16; HMS3744I09; KUC103451N; Pharmakon1600-01505786; HY-B0621; ZINC1444556; Tox21_112231; 1H-Benzimidazole, 6-chloro-5-(2,3-dichlorophenoxy)-2-(methylthio)-; ANW-42745; NSC759250; s4114; STK332284; AKOS005439340; AKOS015950804; AC-7627; API0004496; CCG-100881; CS-2859; DB12245; KS-5329; MCULE-8131756770; MP-0274; NC00131; NSC-759250; SB17173; NCGC00164610-02; BR-68238; I018; LS-32758; SAM001246681; SC-17720; SBI-0207022.P001; AB0013427; AB1004580; AX8034628; CAS-68786-66-3; ST2418930; TR-022940; FT-0602564; SW197511-2; D07364; AB00639964-10; AB00639964_12; AB00639964_13; 786T663; A836250; Q419739; SR-01000759363; SR-01000759363-4; Triclabendazole, VETRANAL(TM), analytical standard; BRD-K81916719-001-05-5; 6-Chloro-5-(2,3-dichlorophenoxy)-2-(methylthio)benzimidazole; 6-CHLORO-5-(2,3-DICHLOROPHENOXY)-2-METHYLTHIO-BENZ; Triclabendazole, EuropePharmacopoeia (EP) Reference Standard; 5-Chloro-6-(2,3-dichlorophenoxy)-2-(methylsulfanyl)-1H-benzimidazole; 5-chloro-6-(2,3-dichlorophenoxy)-2-(methylthio)-1H-benzo[d]imidazole; 6-chloro-5-(2,3-dichlorophenoxy)-2-(methylsulfanyl)-1H-1,3-benzodiazole; 6-chloro-5-(2,3-dichlorophenoxy)-2-(methylsulfanyl)-1H-benzimidazole; Triclabendazole for system suitability, EuropePharmacopoeia (EP) Reference Standard;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C14H9Cl3N2OS",
"molecular_weight": "359.7",
"state": "solid",
"clearance": "",
"volume_of_distribution": "The apparent volume of distribution (Vd) of the sulfoxide metabolite in fed patients is about 1 L/kg.[FDA label]\n",
"route_of_elimination": "No data regarding excretion is available in humans. In animals, triclabendazole is primarily excreted by the biliary tract in the feces (90%), together with the sulfoxide and sulfone metabolite. Less than 10% of an oral dose is found excreted in the urine.[FDA label]",
"protein_binding": "Protein-binding of triclabendazole, sulfoxide metabolite and sulfone metabolite in human plasma was 96.7%, 98.4% and 98.8% respectively.[FDA label]",
"half_life": "The plasma elimination half-life (t1/2) of triclabendazole, the sulfoxide and sulfone metabolites in human is about 8, 14, and 11 hours, respectively.[FDA label]",
"absorption": "After a single oral dose of 10 mg/kg triclabendazole with a 560-kcal meal to patients diagnosed with fascioliasis, mean peak plasma concentrations (Cmax) for triclabendazole, the sulfoxide, and sulfone metabolites were 1.16, 38.6, and 2.29 μmol/L, respectively. The area under the curve (AUC) for triclabendazole, the sulfoxide and sulfone metabolites were 5.72, 386, and 30.5 μmol∙h/L, respectively.[FDA label]\n\nAfter the oral administration of a single dose of triclabendazole at 10 mg/kg with a 560 calorie meal to patients with fascioliasis, the median Tmax for the parent compound as well as the active sulfoxide metabolite was 3 to 4 hours.[FDA label]\n\n**Effect of Food**\nCmax and AUC of triclabendazole and sulfoxide metabolite increased about 2-3 times when triclabendazole was administered as a single dose at 10 mg/kg with a meal containing approximately 560 calories. Additionally, the sulfoxide metabolite Tmax increased from 2 hours in fasting subjects to 4 hours in fed subjects [FDA label].",
"cid": "50248",
"classification": "P",
"indications": "",
"side_effects": "",
"atc_codes": "P02BX04",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02168",
"RC02789",
"RC03410"
]
},
{
"compound_ID": "D1139",
"name": "triclocarban",
"synonyms": "Triclocarban; 101-20-2; 1-(4-Chlorophenyl)-3-(3,4-dichlorophenyl)urea; Solubacter; Cutisan; Procutene; 3,4,4'-TRICHLOROCARBANILIDE; Genoface; Trilocarban; Cusiter; Trichlorocarbanilide; 3,4,4'-Trichlorodiphenylurea; N-(4-Chlorophenyl)-N'-(3,4-dichlorophenyl)urea; Trichlocarban; Triclocarbanum; Urea, N-(4-chlorophenyl)-N'-(3,4-dichlorophenyl)-; TCC; 3,4,4'-trichloro carbanilide; 1-(3',4'-Dichlorophenyl)-3-(4'-chlorophenyl)urea; TCC Soap; Caswell No. 874; ENT 26925; NSC-72005; TCC (soap bacteriostat); UNII-BGG1Y1ED0Y; CP 78416; N-(3,4-Dichlorophenyl)-N'-(4-chlorophenyl)urea; Carbanilide, 3,4,4'-trichloro-; Triclocarban [USAN:INN]; Triclocarbanum [INN-Latin]; C13H9Cl3N2O; NSC 72005; CCRIS 4880; HSDB 5009; EINECS 202-924-1; BGG1Y1ED0Y; EPA Pesticide Chemical Code 027901; BRN 2814890; AI3-26925; CHEBI:48347; ICUTUKXCWQYESQ-UHFFFAOYSA-N; NSC72005; trichlorcarban; NCGC00164034-01; DSSTox_CID_6214; DSSTox_RID_78062; DSSTox_GSID_26214; Q-201865; Septivon-Lavril; CAS-101-20-2; 3,4,4-Trichlorocarbanilide; Nipaguard TCC; 9EG; N-(4-Chlorophenyl)-N-(3,4-dichlorophenyl)-Urea; Urea,4-dichlorophenyl)-; Urea-based compound, 11; Triclocarban (USAN/INN); 3,4'-Trichlorocarbanilide; EC 202-924-1; 3,4'-Trichlorodiphenylurea; cid_7547; NCIOpen2_008923; SCHEMBL68658; WLN: GR DMVMR CG DG; 4-12-00-01265 (Beilstein Handbook Reference); MLS002415563; Carbanilide,4,4'-trichloro-; CHEMBL1076347; DTXSID4026214; BDBM25730; CTK7G5073; Triclocarban, analytical standard; ZINC121480; HY-B1805; KS-000000YY; Tox21_112078; Tox21_202030; Tox21_300481; LS-328; MFCD00013254; s6444; STK730440; 3,4,4'-Trichlorocarbanilide, 99%; AKOS001713711; Tox21_112078_1; CS-7760; DB11155; KS-5290; MCULE-7925567906; TRA0036036; NCGC00164034-02; NCGC00164034-03; NCGC00164034-04; NCGC00164034-05; NCGC00254243-01; NCGC00259579-01; AC-12602; AK163703; SMR001339078; ST011927; AX8081482; TR-000339; FT-0614114; ST24037341; D06223; J10256; 3-(4-chlorophenyl)-1-(3,4-dichlorophenyl)urea; C-49798; Q416579; SR-01000860289; N-(4-chlorophenyl)-N'-(3,4-dichlorophenyl)-urea; SR-01000860289-2; [(3,4-dichlorophenyl)amino]-N-(4-chlorophenyl)carboxamide; US8815951, 3-(4-chlorophenyl)-1-(3,4-dichlorophenyl)urea; Triclocarban, United States Pharmacopeia (USP) Reference Standard; 3,4,4` Trichlorocarbanilide (Triclocarban), Pharmaceutical Secondary Standard; Certified Reference Material;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C13H9Cl3N2O",
"molecular_weight": "315.6",
"state": "solid",
"clearance": "After a pharmacokinetic study in man, radioactivity was rapidly cleared from blood after intravenous administrations of (14)C-triclocarban in propylene glycol with a blood clearance half-life measured to be 8.6 hours [L2685].",
"volume_of_distribution": "",
"route_of_elimination": "The metabolism of (14)C-TCC (3,4,4'-trichlorocarbanilide) has been investigated in humans following oral exposure to 2.2 mumol/kg. Fecal elimination (70% of dose) was complete at the 120 hour point after administration and the urinary excretion (27% of dose) was complete after 80 hours post-administration [L2685].\n\nUrinary glucuronides appear to be valuable biomarkers of triclocarban exposure [A32932].",
"protein_binding": "",
"half_life": "10 hours [L2680]",
"absorption": "A human exposure study in a small group of subjects demonstrated that a portion of the TCC present in bar soaps is absorbed through the skin and is excreted in urine as N-glucuronides [A32932].\n\nBecause they are produced and used in large quantities in various products, they are absorbed into the human body of the general population [L2679].\n\nThe absorption of triclocarban during a human pharmacokinetic study was estimated at 0.6% of the 70 + or - 15 mg of triclocarban in the soap used. The triclocarban-N-glucuronide urine concentration varied considerably among the study subjects, and continuous daily use of the soap led to steady-state levels of excretion [L2685].\n",
"cid": "7547",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02169",
"RC02790",
"RC03411"
]
},
{
"compound_ID": "D1140",
"name": "triclosan",
"synonyms": "triclosan; 3380-34-5; 5-CHLORO-2-(2,4-DICHLOROPHENOXY)PHENOL; 2,4,4'-Trichloro-2'-hydroxydiphenyl ether; Irgasan; Cloxifenolum; Triclosanum; Irgasan DP300; Phenol, 5-chloro-2-(2,4-dichlorophenoxy)-; Stri-Dex Face Wash; Lexol 300; Stri-Dex Cleansing Bar; 5-Chloro-2-(2,4-dichloro-phenoxy)-phenol; Triclosanum [INN-Latin]; CH 3565; DP-300; Caswell No. 186A; C12H7Cl3O2; UNII-4NM5039Y5X; HSDB 7194; CHEBI:164200; Ether, 2'-hydroxy-2,4,4'-trichlorodiphenyl; Phenyl ether, 2'-hydroxy-2,4,4'-trichloro-; EINECS 222-182-2; CHEMBL849; EPA Pesticide Chemical Code 054901; BRN 2057142; 2,4,4'-Trichloro-2'-hydroxy diphenyl ether; XEFQLINVKFYRCS-UHFFFAOYSA-N; 4NM5039Y5X; MFCD00800992; TCL; NCGC00159417-02; NCGC00159417-05; NCGC00159417-06; AK-73001; Aquasept; Sapoderm; DSSTox_CID_12498; DSSTox_RID_78958; DSSTox_GSID_32498; Q-201866; Irgasan DP 300; Cloxifenol; 2-(2,4-dichlorophenoxy)-5-chlorophenol; SMR000471847; Triclosan [USAN:BAN:INN]; CAS-3380-34-5; 2-Hydroxy-2',4,4'-trichlorodiphenyl Ether; Triclosan (USP/INN); SR-01000762974; Trichlorosan; Sterzac; Stri-Dex cleansing bar (TN); CCRIS 9253; Triclosan USP; 1nhg; Triclosan [USAN:USP:INN:BAN]; Triclosan; Irgasan; Irgasan DP 30; TCCP; PubChem9026; CH-3565; Neostrata Antibacterial Facial Cleanser; 3p9t; 4w9n; Epitope ID:119683; SCHEMBL3269; 88032-08-0; KSC498G0D; MLS001066347; MLS001074876; MLS001335937; MLS001335938; BDBM8726; ZINC2216; DTXSID5032498; CTK3J8301; BII1002; ZX-AFC000465; HMS2093L17; HMS2270M06; HMS3259K19; HMS3715H11; Pharmakon1600-01505465; Irgasan, >=97.0% (HPLC); DNDI1246774; HY-B1119; KS-000009AG; Tox21_111648; Tox21_400079; ANW-42338; DP 300; GA5716; NSC759151; s4541; SBB058565; STL451034; Triclosan 100 microg/mL in Methanol; AKOS015850380; Tox21_111648_1; API0004498; CCG-213459; CH-3635; CS-4718; DB08604; KS-5356; MCULE-2614621397; NC00516; NSC-759151; RTR-014090; TRA0068104; Triclosan 10 microg/mL in Cyclohexane; NCGC00159417-03; NCGC00159417-04; NCGC00159417-07; NCGC00159417-08; 2,4,4'-trichloro-2'-hydroxydiphenylethe; AC-10667; BR-73001; CPD000471847; LS-67854; SAM002554907; SC-16588; 5-chloro-2-(2, 4-dichlorophenoxy)phenol; SBI-0206807.P001; AX8020299; ST2411924; TR-014090; 5-chloro-2-(2,4-di-chloro-phenoxy)-phenol; FT-0609773; ST50826110; C12059; D06226; J10025; M-6446; S00100; 5-Chloro-2-(2,4-dichlorophenoxy)phenol, 97%; AB00698074_08; Triclosan, Antibiotic for Culture Media Use Only; 380T345; A821950; C-18186; Q408646; 2-[2,4-bis(chloranyl)phenoxy]-5-chloranyl-phenol; SR-01000762974-2; SR-01000762974-3; BRD-K41731458-001-04-5; BRD-K41731458-001-09-4; Triclosan, certified reference material, TraceCERT(R); F2173-0825; Triclosan, United States Pharmacopeia (USP) Reference Standard; Triclosan, Pharmaceutical Secondary Standard; Certified Reference Material;",
"trade_name": "",
"abbrev_name": "TCS",
"description": "antibacterial and antifungal agent present in some consumer products; aromatic ether",
"molecular_formula": "C12H7Cl3O2",
"molecular_weight": "289.5",
"state": "solid",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "In one study, after in vivo topical application of a 64.5mM alcoholic solution of [(3)H]triclosan to rat skin, 12% radioactivity was recovered in the faeces, 8% in the carcass 1% in the urine, 30% in the stratum corneum and 26% was rinsed from the skin surface at 24 hours after application. [PMID: 10722890]",
"protein_binding": "",
"half_life": "The terminal plasma half life of triclosan is 21 h (Sandborgh-Englund et al., 2006).",
"absorption": "A study conducted in 2000 demonstrated that low amounts of triclosan can be absorbed through skin and can enter the bloodstream. [PMID: 10722890] Triclosan is rapidly absorbed and distributed in the human body (Sandborgh-Englund et al., 2006). Maximum concentrations are reached within three hours after oral intake. However, the metabolism and excretion of the compound is fast.",
"cid": "5564",
"classification": "D",
"indications": "",
"side_effects": "",
"atc_codes": "D08AE04; D09AA06",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108",
"F02010203",
"F02010204",
"F02010205",
"F02010206",
"F02010207"
],
"references": [
"RC01254",
"RC01255",
"RC01256",
"RC01257",
"RC01258",
"RC01318",
"RC01319",
"RC01320",
"RC02170",
"RC02791",
"RC03412"
]
},
{
"compound_ID": "D1141",
"name": "triethoxy(2-methylpropyl)silane",
"synonyms": "Triethoxy(isobutyl)silane; 17980-47-1; Isobutyltriethoxysilane; triethoxy(2-methylpropyl)silane; Triethoxyisobutylsilane; Silane, triethoxy(2-methylpropyl)-; UNII-0YZ0G6Z2XH; 0YZ0G6Z2XH; Dynasylan Ibteo; (2-Methylpropyl)triethoxysilane; iso-butyltriethoxysilane; Triethoxy(isobutyl);silane; EC 402-810-3; DSSTox_CID_24857; DSSTox_RID_80535; DSSTox_GSID_44857; SCHEMBL104863; CHEMBL3186627; DTXSID1044857; Isobutyltriethoxysilane, >=95%; CTK4D7392; triethoxy(2-methylpropyl)-silane; Silane,triethoxy(2-methylpropyl)-; KS-000018IX; Tox21_301397; MFCD00069084; AKOS016011185; ZINC169744737; FS-3836; ACM17980471; NCGC00256052-01; I482; CAS-17980-47-1; FT-0697855; ST24050258; S10150; C-54089; Q27237362;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C10H24O3Si",
"molecular_weight": "220.38",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "87391",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02171",
"RC02792",
"RC03413"
]
},
{
"compound_ID": "D1142",
"name": "triethyltin bromide",
"synonyms": "Triethyltin bromide; Bromotriethylstannane; 2767-54-6; STANNANE, BROMOTRIETHYL-; Triethyl tin bromide; Triethylstannium bromide; Tin, triethyl-, bromide; UNII-UOP17166KC; EINECS 220-443-5; UOP17166KC; triethylstannyl bromide; Stannane,bromotriethyl-; ACMC-1CL7Y; Triethyltin bromide, 97%; DSSTox_CID_20712; DSSTox_RID_79560; DSSTox_GSID_40712; DTXSID9040712; CTK4G0063; KQPIFPBKXYBDGV-UHFFFAOYSA-M; Tox21_301405; AKOS015915639; ZINC170154663; NCGC00164125-01; NCGC00255531-01; CAS-2767-54-6; LS-146462; TC-164805; Q27291173;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C6H15BrSn",
"molecular_weight": "285.8",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "17701",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02172",
"RC02793",
"RC03414"
]
},
{
"compound_ID": "D1143",
"name": "trifluralin",
"synonyms": "trifluralin; 1582-09-8; Treflan; Agreflan; Elancolan; 2,6-Dinitro-N,N-dipropyl-4-(trifluoromethyl)aniline; Crisalin; Triflurex; Trifurex; Tristar; Nitran; Nitran K; Trifluraline; Crisalina; Digermin; Synfloran; Trefanocide; Treficon; Trikepin; Ipersan; Olitref; Super-Treflan; Agriflan 24; Benzenamine, 2,6-dinitro-N,N-dipropyl-4-(trifluoromethyl)-; Treflam; Tri-4; Treflan EC; Su seguro carpidor; Trifluralina 600; Lilly 36,352; PREMERLIN; Treflanocide elancolan; Caswell No. 889; UNII-C8BX46QL7K; Trifluraline [ISO-French]; Trifluralin, technical grade; 2,6-Dinitro-N,N-dipropyl-4-(trifluoromethyl)benzenamine; CCRIS 607; Trifluralin [ANSI:BSI:ISO]; L-36352; 2,6-Dinitro-N,N-dipropyl-4-trifluoromethylaniline; Treflan (trifluralin); HSDB 1003; NCI-C00442; EINECS 216-428-8; EPA Pesticide Chemical Code 036101; alpha,alpha,alpha-Trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidine; N,N-Dipropyl-4-trifluoromethyl-2,6-dinitroaniline; BRN 1893555; C8BX46QL7K; 4-(Trifluoromethyl)-2,6-dinitro-N,N-dipropylaniline; N,N-Di-n-propyl-2,6-dinitro-4-trifluoromethylaniline; AI3-28203; 4-(Di-n-propylamino)-3,5-dinitro-1-trifluoromethylbenzene; CHEBI:35027; ZSDSQXJSNMTJDA-UHFFFAOYSA-N; N,N-Dipropyl-2,6-dinitro-4-trifluoromethylaniline; 2,6-Dinitro-4-trifluormethyl-N,N-dipropylanilin [German]; 2,6-Dinitro-6-trifluormethyl-N,N-dipropylanilin [German]; N,N-Dipropyl-2,6-dinitro-4-trifluormethylanilin [German]; 2,6-Dinitro-N,N-di-n-propyl-alpha,alpha,alpha-trifluoro-p-toluidine; DSSTox_CID_1395; p-Toluidine, .alpha.,.alpha.,.alpha.-trifluoro-2,6-dinitro-N,N-dipropyl-; DSSTox_RID_76136; DSSTox_GSID_21395; Trifluralin, analytical standard; p-Toluidine, alpha,alpha,alpha-trifluoro-2,6-dinitro-N,N-dipropyl-; Trilin 4EC; CAS-1582-09-8; elanocolan; trifuraline; Sinflouran; Brassix; Commence; Trifloran; Zeltoxone; Trilin; Treflan MTF; Treflan 5G; Agriphlan 24; Treflan 4EC; Treflan 10G; Trefl an 10G; Treflan TR-10; TRIFLURALIN EC; Trimaran (Salt/Mix); Spectrum_001839; SpecPlus_000440; TREFLAN(R); Spectrum2_001888; Spectrum3_000830; Spectrum4_000670; Spectrum5_001972; 2,6-Dinitro-4-trifluormethyl-N,N-dipropylanilin; 2,6-Dinitro-6-trifluormethyl-N,N-dipropylanilin; BIDD:PXR0025; N,N-Dipropyl-2,6-dinitro-4-trifluormethylanilin; SCHEMBL21994; BSPBio_002359; KBioGR_001079; KBioSS_002344; SPECTRUM330038; MLS002454453; BIDD:ER0382; CHEMBL31970; DivK1c_006536; SPBio_001796; 2,6-Dinitro-N,N-dipropyl-4-(trifluoromethyl)-benzamine; DTXSID4021395; CTK5E1805; KBio1_001480; KBio2_002341; KBio2_004909; KBio2_007477; KBio3_001859; Benezeneamine, 2,6-dinitro-N,N-dipropyl-4-(trifluoromethyl)-; NCI C00443; EBD43337; HY-B2050; ZINC3873953; Tox21_201352; Tox21_300918; CCG-39426; LS-906; Scotts Stop Weeds Before They Start; STK792949; AKOS005608916; CS-5200; KF10033; KS-5357; MCULE-3549367398; Trifluralin 100 microg/mL in Methanol; NCGC00091301-01; NCGC00091301-02; NCGC00091301-03; NCGC00091301-04; NCGC00091301-05; NCGC00091301-06; NCGC00091301-07; NCGC00091301-08; NCGC00254821-01; NCGC00258904-01; Trifluralin 10 microg/mL in Cyclohexane; 71281-30-6; I703; SMR000778097; ST046418; DB-043382; FT-0603564; EN300-67184; C14343; K-4963; Trifluralin, PESTANAL(R), analytical standard; 582T098; A809905; Q418247; 2,6-dinitro-N,N-dipropyl-4-trifluoromethyl-aniline; 4-DIPROPYLAMINO-3,5-DINITROBENZO-TRIFLUORIDE; J-009482; N,N-dipropyl-2,6-dini tro-4-trifluoromethylaniline; (2,6-Dinitro-4-trifluoromethyl-phenyl)-dipropyl-amine; [2,6-dinitro-4-(trifluoromethyl)phenyl]dipropylamine; 2,6-Dinitro-N,N-dipropyl-4-(trifluoromethyl)aniline #; N,N-di-n-propyl-2,6-dinitro-4-(trifluoromethyl)aniline; 2,6-dinitro-N,N-dipropyl-4-(tri fluoromethyl)benzenamine; 2,6-Dinitro-N,N-dipropyl-4-(trifluoromethyl)benzeneamine; 4-(Di-n-propylamino)-3,5-dinitro-1-(trifluoromethyl)benzene; A,A,A-TRIFLUORO-2,6-DINITRO-N,N-DIPROPYL-P-TOLUIDINE; Benezeneamine, 2,6-di nitro-N,N-dipropyl-4-(trifluoromethyl)-; Benzeneamine, 2,6-dinitro-N,N-dipropyl-4-(trifluoromethyl)-; Trifluralin2,6-dinitro-N,N-dipropyl-4-(trifluoromethyl)aniline; 2,6-dinitro-N,N-dipropyl-alpha,alph a,alpha-trifluoro-p-toluidine; 2,6-dinitro-N,N-dipropyl-alpha,alpha,alpha-trifluoro-p-toluidine; Benzenamine, 2,6-dinitro-N,N-dipropyl-4-(trifluoromethyl)- (9CI); .alpha.,.alpha.,.alpha.-Trifluoro-2,6-dinitro-N,N-dipropyl-p-toluidine; 2,6-Dinitro-N,N-di-n-propyl-.alpha.,.alpha.,.alpha.-trifluoro-p-toluidine; Trifluralin solution, 100 mug/mL in acetonitrile, PESTANAL(R), analytical standard; 75635-23-3; trifluralin;2,6-dinitro-n,n-dipropyl-4-(trifluoromethyl)-benzamine; 4-(di-n-propylamino)-3,5-dinitro-1-trifluoromethylbenzene; alpha,alpha,alpha-trifluoro-2,6-dinitro-n,n-dipropyl-p-toluidine; agrefla;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C13H16F3N3O4",
"molecular_weight": "335.28",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "5569",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02173",
"RC02794",
"RC03415"
]
},
{
"compound_ID": "D1144",
"name": "trihexyltetradecylphosphonium bromide",
"synonyms": "Trihexyltetradecylphosphonium bromide; 654057-97-3; Phosphonium, trihexyltetradecyl-, bromide; trihexyl(tetradecyl)phosphonium bromide; Tetradecyltrihexylphosphonium bromide; DSSTox_CID_27929; DSSTox_RID_82682; DSSTox_GSID_47953; SCHEMBL305729; CHEMBL3185205; DTXSID0047953; CTK1J7023; Tox21_200809; NCGC00258363-01; AS-63459; RT-016122; CAS-654057-97-3; Trihexyltetradecylphosphonium bromide, >=95%; TRIHEXYL(TETRADECYL)PHOSPHANIUM BROMIDE;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C32H68BrP",
"molecular_weight": "563.8",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "16218822",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02174",
"RC02795",
"RC03416"
]
},
{
"compound_ID": "D1145",
"name": "trihexyltetradecylphosphonium chloride",
"synonyms": "Trihexyltetradecylphosphonium chloride; 258864-54-9; TETRADECYL(TRIHEXYL)PHOSPHONIUM CHLORIDE; Phosphonium, trihexyltetradecyl-, chloride; DSSTox_CID_27920; DSSTox_RID_82673; DSSTox_GSID_47944; SCHEMBL245448; CHEMBL3186883; DTXSID1047944; CTK8E6488; JCQGIZYNVAZYOH-UHFFFAOYSA-M; KS-000018SG; Tox21_200697; trihexyl(tetradecyl)phosphanium,chloride; NCGC00258251-01; trihexyl(tetradecyl) phosphonium chloride; RT-016123; CAS-258864-54-9; Trihexyltetradecylphosphonium chloride, >=95.0% (NMR);",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C32H68ClP",
"molecular_weight": "519.3",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "11375816",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02175",
"RC02796",
"RC03417"
]
},
{
"compound_ID": "D1146",
"name": "trihexyltetradecylphosphonium dicyanamide",
"synonyms": "Trihexyltetradecylphosphonium dicyanamide; 701921-71-3; DSSTox_CID_29310; DSSTox_RID_83426; DSSTox_GSID_49351; SCHEMBL2091311; CHEMBL3188352; DTXSID6049351; CTK2H6421; Tox21_202613; NCGC00260161-01; RT-016125; CAS-701921-71-3; T3534; Trihexyltetradecylphosphonium dicyanamide, >=95%;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C34H68N3P",
"molecular_weight": "549.9",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "16217238",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02176",
"RC02797",
"RC03418"
]
},
{
"compound_ID": "D1147",
"name": "trihexyltetradecylphosphonium hexafluorophosphate",
"synonyms": "Trihexyltetradecylphosphonium hexafluorophosphate; 374683-44-0; Trihexyl(tetradecyl)Phosphonium Hexafluorophosphate; DSSTox_CID_27926; DSSTox_RID_82679; DSSTox_GSID_47950; CHEMBL3184345; DTXSID5047950; SCHEMBL21248351; CTK1C1338; Tox21_200750; NCGC00248973-01; NCGC00258304-01; CAS-374683-44-0; Trihexyltetradecylphosphonium hexafluorophosphate, >=95.0% (31P-NMR);",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C32H68F6P2",
"molecular_weight": "628.8",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "16212610",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02177",
"RC02798",
"RC03419"
]
},
{
"compound_ID": "D1148",
"name": "triphenyl phosphate",
"synonyms": "TRIPHENYL PHOSPHATE; 115-86-6; Triphenylphosphate; Phosphoric acid, triphenyl ester; Disflamoll TP; Triphenoxyphosphine oxide; Celluflex TPP; Phosflex TPP; Phosphoric Acid Triphenyl Ester; Trifenylfosfat; Phenyl phosphate ((PhO)3PO); NSC 57868; Trifenylfosfat [Czech]; UNII-YZE19Z66EA; CCRIS 4888; HSDB 2536; EINECS 204-112-2; Triphenyl Phosphate (TPP); BRN 1888236; YZE19Z66EA; AI3-04491; CHEBI:35033; XZZNDPSIHUTMOC-UHFFFAOYSA-N; DSSTox_CID_1952; DSSTox_RID_76423; Triphenyl phosphate, 99+%; DSSTox_GSID_21952; Triphenyl Phosphate TPP; CAS-115-86-6; TPPA; Altal; C18H15O4P; Kronitex TPP; Phosphoric acid triphenyl; ACMC-1CUW3; EC 204-112-2; NCIOpen2_007435; SCHEMBL18116; 4-06-00-00720 (Beilstein Handbook Reference); KSC177M9D; Phenyl phosphate, (PhO)3PO; BIDD:ER0309; Triphenyl phosphate, >=99%; Triphenyl phosphoric acid ester; CHEMBL454511; DTXSID1021952; CTK0H7691; WLN: ROPO & OR & OR; KS-00000V3J; NSC57868; ZINC1688738; Tox21_201511; Tox21_300504; ANW-16910; LS-576; MFCD00003031; NSC-57868; SBB060443; STL280499; AKOS015888630; MCULE-9737362370; RTR-002974; TRA0071969; Triphenyl phosphate, analytical standard; NCGC00164033-01; NCGC00164033-02; NCGC00164033-03; NCGC00254408-01; NCGC00260671-01; AC-19461; H474; TR-002974; FT-0657194; P0272; ST51046617; Triphenylphosphate 100 microg/mL in Methanol; C14235; Triphenyl Phosphate 1000 microg/mL in Acetone; A803498; Q418573; Triphenyl phosphate 10 microg/mL in Ethyl acetate; J-003328; Triphenyl phosphate, TraceCERT(R), 31P-qNMR Standard; Triphenyl phosphate 500 microg/ml in Methyl-tert-butyl ether; Triphenyl phosphate (TPP) 500 microg/mL in Methyl tert-butyl ether; Triphenyl phosphate solution, certified reference material, 500 mug/mL in methyl tert-butyl ether; Triphenyl phosphate solution, NMR reference standard, 0.03357 M in chloroform-d (99.8 atom % D), NMR tube size 5 mm x 8 in.; Triphenyl phosphate solution, NMR reference standard, 0.0485 M in acetone-d6 (99.9 atom % D); Triphenyl phosphate solution, NMR reference standard, 0.0485 M in acetone-d6 (99.9 atom % D), NMR tube size 10 mm x 8 in.; Triphenyl phosphate solution, NMR reference standard, 0.0485 M in acetone-d6 (99.9 atom % D), NMR tube size 3 mm x 8 in.; Triphenyl phosphate solution, NMR reference standard, 0.0485 M in acetone-d6 (99.9 atom % D), NMR tube size 5 mm x 8 in.; Triphenyl phosphate solution, NMR reference standard, 0.0485 M in chloroform-d (99.8 atom % D), NMR tube size 10 mm x 8 in.; Triphenyl phosphate solution, NMR reference standard, 0.0485 M in chloroform-d (99.8 atom % D), NMR tube size 5 mm x 8 in.; Triphenyl phosphate solution, NMR reference standard, 0.0485 M in chloroform-d (99.8 atom % D), NMR tube size 8 mm x 8 in.; Triphenyl phosphate solution, NMR reference standard, 0.485 M in chloroform-d (99.8 atom % D), NMR tube size 3 mm x 8 in.; Triphenyl phosphate solution, NMR reference standard, 3 mM in chloroform-d (99.8 atom % D), NMR tube size 5 mm x 8 in.;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C18H15O4P",
"molecular_weight": "326.3",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "8289",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02178",
"RC02799",
"RC03420"
]
},
{
"compound_ID": "D1149",
"name": "triphenylethylene",
"synonyms": "TRIPHENYLETHYLENE; 58-72-0; Triphenylethene; Ethylene, triphenyl-; Benzilidenediphenylmethane; 1,1,2-Triphenylethylene; Ethene-1,1,2-triyltribenzene; (1,2-Diphenylvinyl)benzene; 1,2,2-Triphenylethylene; Benzene, 1,1',1''-(1-ethenyl-2-ylidene)tris-; UNII-S4ZLZ1K74B; EINECS 200-395-1; NSC 17535; S4ZLZ1K74B; CHEBI:35034; MKYQPGPNVYRMHI-UHFFFAOYSA-N; C20H16; 1,2-diphenylethenylbenzene; 1,2-diphenylvinylbenzene; triphenyl-ethene; MFCD00004765; 1,2-Triphenylethylene; ACMC-1AOGF; Triphenylethylene, 99%; DSSTox_CID_2320; DSSTox_RID_76547; DSSTox_GSID_22320; BIDD:ER0166; (1,2-Diphenylvinyl)benzene #; CHEMBL3115201; DTXSID3022320; CTK3J2210; NSC17535; ZINC1758809; ZX-AT008222; Tox21_302425; ANW-33024; KM0232; NSC-17535; OR9099; SBB056973; AKOS015903680; MCULE-7510612663; CAS-58-72-0; KS-000014K8; NCGC00255197-01; AC-10375; AS-13154; H475; LS-68556; 1,1',1''-ethene-1,1,2-triyltribenzene; AX8034201; RT-000386; ST2419273; FT-0651751; ST50406241; Benzene,1',1''-(1-ethenyl-2-ylidene)tris-; C14134; 004T765; AB-016/30004060; Q25100760;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C20H16",
"molecular_weight": "256.3",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "6025",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02179",
"RC02800",
"RC03421"
]
},
{
"compound_ID": "D1150",
"name": "triphenyltin acetate",
"synonyms": "Fentin acetate; TRIPHENYLTIN ACETATE; Phentin acetate; Phentinoacetate; Brestan; 900-95-8; Fentinacetat; Liromatin; Lirostanol; Tinestan; Batasan; Acetoxytriphenylstannane; Suzu; Fenolovo acetate; Tin triphenyl acetate; Triphenylaceto stannane; Acetatotriphenylstannane; Brestan 60; Fentine acetate; Triphenyl-zinnacetat; Fentin acetaat; Fentin azetat; Fintin acetato; Stannane, (acetyloxy)triphenyl-; Phenostat A; TPTA; TPZA; Acetoxytriphenyltin; Trifenyl-tinacetaat; Tinestan 60 wp; Triphenylstannium acetate; Acetoxy-triphenyl-stannan; Fentin acetat; Stannane, acetoxytriphenyl-; Tin, acetoxytriphenyl-; Triphenyltin(IV) acetate; Tinestan WP 20; Tinestan WP 60; Acetate de triphenyl-etain; Acetato di stagno trifenile; (Acetyloxy)triphenylstannane; Trifenil stagno acetato; triphenylstannyl acetate; Fentin acetate [BSI]; Acetoxy-triphenylstannane; Acetic acid, triphenylstannyl ester; HOE-2824; ENT 25208; Caswell No. 896C; Fentin acetaat [Dutch]; Fentin acetat [German]; Fentin azetat [German]; GC 6936; Fentine acetate [French]; Fintin acetato [Italian]; VP 19-40; OMS 1020; Trifenyl-tinacetaat [Dutch]; NSC 76068; Triphenyl-zinnacetat [German]; (Acetyloxy)(triphenyl)stannane; CCRIS 8605; HSDB 1783; Trifenil stagno acetato [Italian]; Acetoxy-triphenyl-stannan [German]; Acetate de triphenyl-etain [French]; EINECS 212-984-0; Acetato di stagno trifenile [Italian]; EPA Pesticide Chemical Code 496700; BRN 4146107; AI3-25208; m-Nitrobenzaldehyde 3-thio-4-o-tolylsemicarbazone; Benzaldehyde, m-nitro-, 3-thio-4-o-tolylsemicarbazone; Fentin acetat (german); Triphenyl-zinnacetat (german); Acetoxy-triphenyl-stannan (german); Fentin acetate [BSI:ISO]; Fentin-acetate; Acetoxytriphenyl-Tin; Acetoxytriphenyl-Stannane; acetoxy(triphenyl)stannane; DSSTox_CID_1408; DSSTox_RID_76144; DSSTox_GSID_21408; SCHEMBL68978; (acetyloxy)triphenyl-Stannane; WLN: 1VO-SN-R&R&R; DTXSID6021408; CHEBI:81918; (Acetyloxy)(triphenyl)stannane #; Vp 1940; NSC76068; Tox21_202600; NSC-76068; AKOS015902800; ZINC169795090; LS-7742; NCGC00166128-01; NCGC00260148-01; 900-45-8; CAS-900-95-8; DB-057182; FT-0603522; C18728; Fentin acetate, PESTANAL(R), analytical standard; Q168685; W-100342;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C20H18O2Sn",
"molecular_weight": "409.1",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "16682804",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02180",
"RC02801",
"RC03422"
]
},
{
"compound_ID": "D1151",
"name": "triphenyltin fluoride",
"synonyms": "TRIPHENYLTIN FLUORIDE; 379-52-2; Fentin fluoride; Stannane, fluorotriphenyl-; Fluorotriphenylstannane; Biomet 204; Tin, fluorotriphenyl-; Caswell No. 896H; UNII-1YP2L952MD; EINECS 206-833-8; EPA Pesticide Chemical Code 083602; 1YP2L952MD; Fluorotriphenyltin; Triphenylzinnfluorid; Stannane,fluorotriphenyl-; Fluorotriphenylstannane 98%; DSSTox_CID_22500; DSSTox_RID_80041; DSSTox_GSID_42500; DTXSID3042500; CTK4H9063; Tox21_302241; MFCD00015356; ZINC169811512; NCGC00255906-01; CAS-379-52-2; LS-146561; FT-0704230; C-52558; Q27253227;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C18H15FSn",
"molecular_weight": "369",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "9786",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02181",
"RC02802",
"RC03423"
]
},
{
"compound_ID": "D1152",
"name": "triphenyltin hydroxide",
"synonyms": "Triphenyltin hydroxide; FENTIN HYDROXIDE; Triphenylstannanol; Hydroxytriphenyltin; 76-87-9; Vancide ks; Hydroxytriphenylstannane; Erithane; Fenolovo; Tenhide; Stannane, hydroxytriphenyl-; Tptoh; Duter extra; Triphenyltin oxide; Dowco 186; Du-Ter; Suzu H; Haitin; Stannol, triphenyl-; Fintin hydroxid; TPTH; Fintin hydroxyde; Fintin idrossido; Phenostat-H; Sunitron H; Fintine hydroxyde; Tin, hydroxytriphenyl-; Du-Ter W-50; Trifenyl-tinhydroxyde; Triphenyl-zinnhydroxid; Flo-Tin 4L; Tpth Technical; Triphenyl tin hydroxide; Du-Ter Fungicide; Triple Tin 4l; Triphenylstannium hydroxide; Vito Spot Fungicide; Fentin [ISO]; Flo Tin 4l; NCI-C00260; Hydroxyde de triphenyl-etain; Idrossido di stagno trifenile; Du-Tur Flowable-30; ENT 28009; Trifenylstanniumhydroxid; Caswell No. 896E; Fentine [ISO-French]; Fentin hydroxide [BSI]; Ida, Imc Flo-Tin 4L; Fintin hydroxid [German]; Fintin hydroxyde [Dutch]; K 19; Triphenyltin(IV) hydroxide; Du-Ter PB-47 Fungicide; Fintin idrossido [Italian]; Fintine hydroxide [French]; Fintine hydroxyde [French]; OMS 1017; CCRIS 612; Trifenyl-tinhydroxyde [Dutch]; NSC 113243; Brestan H 47.5 WP fungicide; Triphenyl-zinnhydroxid [German]; Trifenylstanniumhydroxid [Czech]; Du-Ter Fungicide Wettable Powder; HSDB 1784; K 19 (VAN); EINECS 200-990-6; Hydroxyde de triphenyl-etain [French]; EPA Pesticide Chemical Code 083601; Wesley Technical Triphenyltin Hydroxide; BRN 4139186; Haitin WP 20 (fentin hydroxide 20%); Haitin WP 60 (fentin hydroxide 60%); Idrossido di stagno trifenile [Italian]; Super Tin 4L Gardian Flowable Fungicide; AI3-28009; K19; Duter; Fintine hydroxide; C18H16OSn; Farmatin; Ashlade flotin; Fentin-hydroxide; Super-tin; Triple Tin; Brestan R; Super Tin; Phenostat-A H; Super tin 4l; Suzu-H; Super tin 4 L; Sn(OH)Ph3; hydroxy(triphenyl)stannane; DSSTox_CID_1409; [Sn(OH)Ph3]; triphenylstannylium hydroxide; DSSTox_RID_76145; WLN: Q-SN-R&R&R; DSSTox_GSID_21409; SCHEMBL70052; DTXSID1021409; CHEBI:30473; Tox21_300754; MFCD00013928; NSC113243; AKOS015960675; ZINC169876287; LS-1696; NSC-113243; CAS-76-87-9; NCGC00163909-01; NCGC00163909-02; NCGC00163909-03; NCGC00163909-04; NCGC00254659-01; O595; C18729; C-21050; Fentin hydroxide, PESTANAL(R), analytical standard; Q7843285;",
"trade_name": "",
"abbrev_name": "",
"description": "organotin compound; fungicide",
"molecular_formula": "C18H17OSn",
"molecular_weight": "368",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "6327657",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108",
"F020403"
],
"references": [
"RC02182",
"RC02803",
"RC03424",
"RC04961"
]
},
{
"compound_ID": "D1153",
"name": "tris(2,3-dibromopropyl) phosphate",
"synonyms": "Tris(2,3-dibromopropyl) phosphate; 126-72-7; Tris(2,3-dibromopropyl)phosphate; TDBPP; Anfram 3PB; Flacavon R; Flammex AP; Zetofex ZN; Tris (flame retardant); Tris-BP; Tdbp; Firemaster T23p-lv; Flammex T 23P; Zetifex zn; Flamex T 23P; Usaf do-41; Bromkal P 67-6HP; Firemaster T23P; Firemaster LV-T 23P; Phoscon UF-S; FireMaster T 23; Phoscon PE 60; Flammex LV-T 23P; Fyrol HB 32; Tris(dibromopropyl) phosphate; (2,3-Dibromopropyl) phosphate; 3PBR; Rcra waste number U235; 2,3-Dibromo-1-propanol phosphate; APEX 462-5; NCI-C03270; T 23P; FireMaster T 23P; Fyrol HB32; TDBP [Czech]; Tris (VAN); NSC 3240; Tris(dibromopropyl)phosphate; CCRIS 614; 1-Propanol, 2,3-dibromo-, phosphate (3:1); Tris-(2,3-dibrompropyl)fosfat; 2,3-Dibromo-1-propanol phosphate (3:1); HSDB 2581; ES685; Tris(2,3-dibromopropyl) phosphoric acid ester; EINECS 204-799-9; ES 685; Phosphoric acid, tris(2,3-dibromopropyl) ester; Tris-2,3-dibrompropyl ester kyseliny fosforecne; RCRA waste no. U235; 1-Propanol, 2,3-dibromo-, 1,1',1''-phosphate; BRN 1915153; Tris-(2,3-dibrompropyl)fosfat [Czech]; AI3-19170; CHEBI:82282; TRIS(2,3-DIBROMO-1-PROPYL) PHOSPHATE; PQYJRMFWJJONBO-UHFFFAOYSA-N; 1-Propanol,2,3-dibromo-, 1,1',1''-phosphate; Tris-2,3-dibrompropyl ester kyseliny fosforecne [Czech]; DSSTox_CID_1413; DSSTox_RID_76148; DSSTox_GSID_21413; CAS-126-72-7; TRIS-(2,3-DIBROMOPROPYL)PHOSPHATE; firemaster t23p-lv; 2,3-Dibromopropyl phosphate; SCHEMBL26576; tr is(dibromopropyl)phosphate; CHEMBL1904600; DTXSID5021413; CTK4B5321; PQYJRMFWJJONBO-UHFFFAOYSA-; NSC3240; NSC-3240; Tox21_201798; Tox21_302967; tris-(2,3-dibromopropyl) phosphate; LS-704; Tris(2,3-dibromo-1-propyl)phosphate; AKOS015914154; 1-Propanol, 2,3-dibromo-, phosphate; NCGC00163880-01; NCGC00163880-02; NCGC00256444-01; NCGC00259347-01; Phosphoric acid tris(2,3-dibromopropyl); WLN: E1YE1OPO & O1YE1EO1YE1E; TBPP, PESTANAL(R), analytical standard; 1-Propanol,3-dibromo-, phosphate (3:1); DB-041837; Phosphoric acid tri(2,3-dibromopropyl) ester; C19182; C-50872; J-005427; Q2443865; Tris(2,3-dibromopropyl) phosphate, analytical standard; 1-[bis(2,3-dibromopropoxy)phosphoryloxy]-2,3-dibromo-propane; InChI=1/C9H15Br6O4P/c10-1-7(13)4-17-20(16,18-5-8(14)2-11)19-6-9(15)3-12/h7-9H,1-6H2;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C9H15Br6O4P",
"molecular_weight": "697.6",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "31356",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02183",
"RC02804",
"RC03425"
]
},
{
"compound_ID": "D1154",
"name": "tyrphostin 23",
"synonyms": "Tyrphostin 23; 118409-57-7; Tyrphostin A23; AG 18; RG-50810; AG-18; (3,4-Dihydroxybenzylidene)malononitrile; Tyrphostin AG18; 2-(3,4-dihydroxybenzylidene)malononitrile; 2-[(3,4-dihydroxyphenyl)methylidene]propanedinitrile; Tyrphostin RG50810; ag18; UNII-RV0GCD31OJ; alpha-Cyano-(3,4-dihydroxy)cinnamonitrile; Propanedinitrile,2-[(3,4-dihydroxyphenyl)methylene]-; RG 50810; (3,4-Dihydroxyphenyl)methylene propanedinitrile; RV0GCD31OJ; C10H6N2O2; NCGC00016043-03; (3,4-dihydroxybenzylidene)propanedinitrile; DSSTox_CID_25215; DSSTox_RID_80754; DSSTox_GSID_45215; Propanedinitrile, ((3,4-dihydroxyphenyl)methylene)-; CAS-118409-57-7; SR-01000075506; tyrphostin-23; 3,4-dihydroxybenzylidenemalononitrile; Tocris-0493; ACMC-20dhi7; ag-18-tyrphostin-23; BiomolKI_000011; Lopac-T-7165; BiomolKI2_000021; cid_2052; Lopac0_001160; Oprea1_072726; AG 18 (Tyrphostin 23); Tyrphostin 23, >=98%; MLS002153315; CHEMBL76904; SCHEMBL241922; BDBM4339; BMK1-B11; DTXSID9045215; CHEBI:92862; CTK4B0662; ZINC15331; AOB5120; EX-A901; VTJXFTPMFYAJJU-UHFFFAOYSA-N; HMS2233I22; HMS3263H21; HMS3266E18; HMS3369M02; HMS3414G15; HMS3653D19; HMS3678G15; BCP06838; Tox21_110287; Tox21_501160; 2085AH; 2773AH; BBL008106; HSCI1_000108; MCK100778; MFCD00133899; s8009; STL139213; TX 825; 3,4-Dihydroxybenzylidene malononitrile; AKOS005715658; Tox21_110287_1; AG18;Tyrphostin 23; RG-50810; CCG-100615; CS-1387; LP01160; MCULE-8159081339; 3,4-(Dihydroxybenzylidene)malononitrile; KS-0000185K; NCGC00016043-01; NCGC00016043-02; NCGC00016043-04; NCGC00016043-05; NCGC00016043-06; NCGC00016043-07; NCGC00016043-08; NCGC00024615-01; NCGC00024615-02; NCGC00024615-03; NCGC00024615-04; NCGC00261845-01; AC-30286; AK326227; AS-69033; benzylidenemalononitrile (BMN) deriv. 23; HY-15644; SC-95402; SMR001230729; AB0152128; DB-093180; LS-172378; RT-016155; 2-(3,4-Dihydroxy-benzylidene)-malononitrile; 4CH-004570; EU-0101160; FT-0675716; SW219523-1; EC-000.2086; T 7165; W-5079; [(3,4-Dihydroxyphenyl)methylene]-propenedinitrile; J-003744; SR-01000075506-1; SR-01000075506-3; SR-01000075506-6; BRD-K49657628-001-02-3; BRD-K49657628-001-03-1; BRD-K49657628-001-05-6; Q27164614;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C10H6N2O2",
"molecular_weight": "186.17",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "2052",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02185",
"RC02806",
"RC03427"
]
},
{
"compound_ID": "D1155",
"name": "vatalanib",
"synonyms": "Vatalanib; 212141-54-3; Vatalanib base; N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine; PTK787; Pynasunate; Vatalinib; CGP 79787; Vatalanib free base; PTK-787; Vatalanib (free base); ZK-232934; CGP-79787; ZK222584; PTK/ZK; CHEMBL101253; UNII-5DX9U76296; 1-Phthalazinamine,N-(4-chlorophenyl)-4-(4-pyridinylmethyl)-; CHEBI:90620; YCOYDOIWSSHVCK-UHFFFAOYSA-N; 1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine; 5DX9U76296; NCGC00181350-01; N-(4-Chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine; DSSTox_CID_26919; DSSTox_RID_82015; DSSTox_GSID_46919; ZK-222584; 1-Phtalazinamine, N-(4-chlorophenyl)-4-(4-pyridinylmethyl)-; N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)-1-phthalazinamine; N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)phtalazin-1-amine; 1-Phthalazinamine, N-(4-chlorophenyl)-4-(4-pyridinylmethyl)-; CAS-212141-54-3; SR-05000001457; CGP-797870; Kinome_3657; Vatalanib (USAN/INN); Vatalanib [USAN:INN]; NVP-PTK787; SCHEMBL18286; C20H15ClN4; BDBM4851; BIFK0006; cid_151194; GTPL5705; ZINC7460; DTXSID2046919; CTK4E6114; QCR-126; ZX-AFC002994; (A) PTK787; BCPP000021; HMS2089D11; HMS3713O04; HMS3745G07; ACT06794; BCP16436; CGP-7978; CGP79787; EX-A1398; Tox21 112808; Tox21_112808; AKOS015896483; Tox21_112808_1; API0004576; CCG-220471; CS-5248; DB04879; MCULE-3078477385; SB16582; BAY-86-5127; NCGC00181350-03; NCGC00181350-06; AC-25025; AS-17435; HY-10203; AB0019678; AB1004881; DB-066452; LS-187006; LS-187641; RT-016221; A1778; FT-0657115; VU0549317-1; D06285; AB01275455-01; 139368-EP2270008A1; 139368-EP2292617A1; 141V543; A815203; 1-(4-Chloranilino)-4-(4-pyridylmethyl)-phthalazin; 1-(4-chloranilino)-4-(4-pyridylmethyl)-phthalazine; K-222584; Q7917084; SR-05000001457-1; SR-05000001457-2; 1 -(4-Chloroanilino)-4-(4-pyridylmethyl)phthalazine; BRD-K70163715-001-02-8; F9995-0196; 1-(4-chlor-anilino)-4-(pyridin-4-yl-methyl)-phthalazine; (4-chlorophenyl)-(4-pyridin-4-ylmethyl-phthalazin-1-yl)amine; (4-chlorophenyl)-[4-(4-pyridylmethyl)phthalazin-1-yl]amine; N-(p-chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C20H15ClN4",
"molecular_weight": "346.8",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "151194",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02186",
"RC02807",
"RC03428"
]
},
{
"compound_ID": "D1156",
"name": "vitamin d3",
"synonyms": "Vitamin D3; cholecalciferol; 67-97-0; Calciol; Colecalciferol; VITAMIN D; Oleovitamin D3; Arachitol; Ricketon; Trivitan; Deparal; Vigorsan; Activated 7-dehydrocholesterol; Colecalcipherol; Delsterol; Ebivit; Quintox; Cholecalciferolum; (+)-Vitamin D3; D3-Vicotrat; D3-Vigantol; vitamin d-3; Vi-de-3-hydrosol; NEO Dohyfral D3; Vitinc Dan-Dee-3; Rampage; Colecalciferolum; Cholecalciferol, D3; Vi-De3; Colecalciferolo [DCIT]; 1406-16-2; Duphafral D3 1000; FeraCol; Colecalciferolum [INN-Latin]; 7-Dehydrocholestrol, activated; Irradiated 7-dehydrocholesterol; CCRIS 5813; CCRIS 6286; HSDB 820; 7-Dehydrocholesterol, irradiated; CC; CHEBI:28940; Vitamin D3 emulsifiable; EINECS 200-673-2; EINECS 215-797-2; MFCD00078131; EPA Pesticide Chemical Code 202901; NSC 375571; 9,10-Secocholesta-5,7,10(19)-trien-3-beta-ol; Provitina; 7-Dehydrocholesterol activated; Micro-dee; QYSXJUFSXHHAJI-YRZJJWOYSA-N; VidDe-3-hydrosol; NSC-375571; 9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3-ol; Colecalciferol (INN); Colecalciferol [INN]; NCGC00159331-02; (3beta,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol; (5Z,7E)-(3S)-9,10-seco-5,7,10(19)-cholestatrien-3-ol; (5Z,7E)-(3S)-9,10-secocholesta-5,7,10(19)-trien-3-ol; 9,10-Secocholesta-5,7,10(19)-trien-3-ol, (3beta,5Z,7E)-; DSSTox_CID_6294; DSSTox_RID_78090; DSSTox_GSID_26294; Devaron; (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol; Vitamin D3 (Cholecalciferol); UNII-1C6V77QF41; Vitamin D3, 99%, crystalline; 9,10-Seco(5Z,7E)-5,7,10(19)-cholestatrien-3beta-ol; Colecalciferolo; (3S,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol; 9,10-Secocholesta-5(Z),7(E),10(19)-trien-3(.beta.)-ol; 9,10-Secocholestra-5,7,10(19)-trien-3-ol, (3beta,5Z,7E)-; Vigantol Oil; Colecalciferol D3; Vitamin D 3; (1S,3Z)-3-[(2E)-2-[(1R,3AR,7AS)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENE-CYCLOHEXAN-1-OL; Vitamin D3; Cholecalciferol; 1C6V77QF41; Videkhol; cholecalciferol (Vitamin D3); NSC375571; 22350-41-0; Granuvit D3; Cholecalciferol [USAN:BAN:JAN]; Delta-D; DP-R206; CAS-67-97-0; Prestwick_63; Cholecalciferol D3; Cyclohexanol, 3-((2E)-2-((1R,3aS,7aR)-1-((1R)-1,5-dimethylhexyl)octahydro-7a-methyl-4H-inden-4-ylidene)ethylidene)-4-methylene-, (1S,3Z)-; Cyclohexanol, 3-[(2E)-2-[(1R,3aS,7aR)-1-[(1R)-1,5-dimethylhexyl]octahydro-7a-methyl-4H-inden-4-ylidene]ethylidene]-4-methylene-, (1S,3Z)-; Cholecalciferol [USP:BAN:JAN:ISO]; (5e)-cholecalciferol; ()-Vitamin D3; Delta-D (TN); Prestwick3_000429; vitamin-d3-cholecalciferol; bmse000507; UPCMLD-DP152; SCHEMBL3126; CHEMBL1042; BSPBio_000418; Cholecalciferol (JP17/USP); BPBio1_000460; MEGxm0_000458; DTXSID6026294; UPCMLD-DP152:001; ACon1_001997; HMS2096E20; Vitamin d assay system suitability; Cholecalciferol, >=98% (HPLC); Cholecalciferol, analytical standard; ZINC4474460; Tox21_111578; Tox21_202546; BDBM50030475; LMST03020001; LS-825; s4063; AKOS015950641; AC-8884; CS-1179; DB00169; LS-1570; SMP1_000068; NCGC00091072-01; NCGC00159331-04; NCGC00260095-01; AK172611; HY-15398; K119; SC-18322; 9,10-secocholesta-5,7,10-trien-3-ol; Cholecalciferol (D3), analytical standard; AB1002422; 3412-EP2314590A1; 3412-EP2316832A1; 3412-EP2316833A1; 7058-EP2305662A1; C05443; D00188; W-5072; 86554-EP2270000A1; 86554-EP2272827A1; 86554-EP2289483A1; 86554-EP2305640A2; 86554-EP2305684A1; 9,10-Secocholesta-5,7,10(19)-trien-3-ol; Cholecalciferol, meets USP testing specifications; 078V131; 9,10-Secocholesta-5,7,10(19)-trien-3?-ol; Q139347; (5E,7E)-9,10-Secocholesta-5,7,10-trien-3-ol; Q-201931; (3S,5Z,7E)-9,10-Secocholesta-5,7,10-trien-3-ol; 3-beta,Z,7E-9,10-Secocholestr-5,7,10(19)-trien-3-ol; Vitamin D3 solution, 100 mug/mL in ethanol, 97% (CP); (3beta,Z,7E)-9,10-Secocholesta-5,7,10(19)-trien-3-ol; Cholecalciferol, European Pharmacopoeia (EP) Reference Standard; Colecalciferol, British Pharmacopoeia (BP) Reference Standard; Cholecalciferol, United States Pharmacopeia (USP) Reference Standard; (+)-Vitamin D3;Cholecalciferol ; Activated 7-dehydrocholesterol; Calciol; Cholecalciferol for system suitability, European Pharmacopoeia (EP) Reference Standard; Cholecalciferol Impurity A (5,6-trans-Cholecalciferol, 5,6-trans-Vitamin D3); Vitamin D3 solution, 1 mg/mL in ethanol, ampule of 1 mL, certified reference material; (1S,3E)-3-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexan-1-ol; (1S,3Z)-3-[(2E)-2-[(1R,3aS,7aR)-1-[(1R)-1,5-dimethylhexyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexanol; Cholecalciferol (Vitamin D3), Pharmaceutical Secondary Standard; Certified Reference Material;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C27H44O",
"molecular_weight": "384.6",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "5280795",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02188",
"RC02809",
"RC03430"
]
},
{
"compound_ID": "D1157",
"name": "zafirlukast",
"synonyms": "zafirlukast; 107753-78-6; Accolate; Olmoran; ICI-204219; Cyclopentyl (3-(2-methoxy-4-((o-tolylsulfonyl)carbamoyl)benzyl)-1-methyl-1H-indol-5-yl)carbamate; Accoleit; Vanticon; ICI 204219; C31H33N3O6S; ICI 204,219; UNII-XZ629S5L50; Cyclopentyl 3-(2-methoxy-4-((o-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate; Zafirlukast (Accolate); CHEMBL603; Aeronix; CHEBI:10100; XZ629S5L50; 4-(5-cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-o-tolylsulfonylbenzamide; NCGC00164547-01; NCGC00164547-06; CPD000466316; DSSTox_CID_3746; DSSTox_RID_77181; DSSTox_GSID_23746; Carbamic acid, (3-((2-methoxy-4-((((2-methylphenyl)sulfonyl)amino)carbonyl)phenyl)methyl)-1-methyl-1H-indol-5-yl)-, cyclopentyl ester; cyclopentyl 3-[2-methoxy-4-(2-methylphenylsulfonylcarbamoyl)benzyl]-1-methyl-1H-indol-5-ylcarbamate; Q-201940; Zafirst; Respix; Accolate (TN); cyclopentyl N-{3-[(2-methoxy-4-{[(2-methylbenzene)sulfonyl]carbamoyl}phenyl)methyl]-1-methyl-1H-indol-5-yl}carbamate; N-[3-[[2-Methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]carbamic Acid Cyclopentyl Ester; SMR000466316; Zafirlukast [USAN:BAN:INN]; CAS-107753-78-6; SR-01000759386; Zafirlukast (JAN/USAN/INN); Zafirlukast [USAN:INN:BAN]; Zafirlukast(Accolate); PubChem18223; ACMC-209wlw; Accolate;Accoleit;Vanticon; cc-92; SCHEMBL4175; 4-(5-cyclopentyloxycarbonylamino-2-methylindol-3-yl-methyl)-3-methoxy-N-O-tolylsulfonylbenzamide; MLS000759421; MLS001424064; MLS006011771; BIDD:GT0267; GTPL3322; DTXSID5023746; CTK4A5698; Zafirlukast, >=98% (HPLC); YEEZWCHGZNKEEK-UHFFFAOYSA-N; HMS2051F12; HMS2089J10; HMS3393F12; HMS3650A04; HMS3655E13; HMS3713J08; HMS3745K03; ZINC896717; BCP05226; KS-00001D9L; Tox21_112176; ANW-46530; BDBM50009073; BG0591; BG0649; GP6218; MFCD00864775; s1633; STK646780; AKOS005577888; Tox21_112176_1; AC-9018; CCG-101025; CS-2167; DB00549; MCULE-2053856450; NC00275; RTR-001857; SB19079; NCGC00164547-02; NCGC00164547-03; NCGC00164547-04; NCGC00164547-05; AS-12943; BR-72849; CC-35662; cyclopentyl (1-methyl-3-{[2-(methyloxy)-4-({[(2-methylphenyl)sulfonyl]amino}carbonyl)phenyl]methyl}-1H-indol-5-yl)carbamate; cyclopentyl [3-(2-methoxy-4-{[(2-methylphenyl)sulfonyl]carbamoyl}benzyl)-1-methyl-1H-indol-5-yl]carbamate; cyclopentyl N-[3-[[2-methoxy-4-(o-tolylsulfonylcarbamoyl)phenyl]methyl]-1-methyl-indol-5-yl]carbamate; HY-17492; LS-50025; SAM001246577; SC-45160; ZINC000000896717; AB0012638; AB2000178; ST2406760; TR-001857; 4CH-018070; FT-0601575; MLS000759421-02; SW197655-3; C07206; D00411; 32256-EP2270008A1; 32256-EP2280006A1; 32256-EP2281813A1; 32256-EP2281815A1; 32256-EP2281819A1; 32256-EP2284166A1; 32256-EP2292617A1; 32256-EP2292619A1; 32256-EP2295409A1; 32256-EP2298415A1; 32256-EP2301933A1; 32256-EP2305640A2; 32256-EP2305659A1; 32256-EP2308562A2; 32256-EP2311818A1; 32256-EP2311827A1; AB00639922-06; AB00639922-08; AB00639922_09; 753Z786; A801752; C-23263; L001011; Q928378; SR-01000759386-4; SR-01000759386-5; SR-01000759386-9; BRD-K71289571-001-06-4; Z1551429730; cyclopentyl 3-(2-methoxy-4-(o-tolylsulfonylcarbamoyl)benzyl)-1-methyl-1H-indol-5-ylcarbamate; cyclopentyl N-[3-({2-methoxy-4-[(2-methylbenzenesulfonyl)carbamoyl]phenyl}methyl)-1-methyl-1H-indol-5-yl]carbamate; cyclopentyl N-[3-[[2-methoxy-4-[(2-methylphenyl)sulfonylcarbamoyl]phenyl]methyl]-1-methyl-indol-5-yl]carbamate; Cyclopentyl N-[3-[[2-Methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]carbamate; N-[3-[[2-methoxy-4-[[(2-methylphenyl)sulfonylamino]-oxomethyl]phenyl]methyl]-1-methyl-5-indolyl]carbamic acid cyclopentyl ester; ZLK;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C31H33N3O6S",
"molecular_weight": "575.7",
"state": "solid",
"clearance": "* apparent oral CL=20 L/h\n* 11.4 L/h [7-11 yrs]\n* 9.2 L/h [5-6 yrs]",
"volume_of_distribution": "* 70 L",
"route_of_elimination": "The most common metabolic products are hydroxylated metabolites which are excreted in the feces.",
"protein_binding": "0.99",
"half_life": "10 hours",
"absorption": "Rapidly absorbed following oral administration, reduced following a high-fat or high-protein meal.",
"cid": "5717",
"classification": "R",
"indications": "",
"side_effects": "",
"atc_codes": "R03DC01",
"group": "Drug",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02189",
"RC02810",
"RC03431"
]
},
{
"compound_ID": "D1158",
"name": "zearalenone",
"synonyms": "ZEARALENONE; 17924-92-4; trans-Zearalenone; (-)-Zearalenone; (S)-Zearalenone; F-2 toxin; (10S)-Zearalenone; Mycotoxin F2; (S)-(-)-Zearalenone; Zenone; Compound F-2; F2 Toxin; Toxin F2; CCRIS 623; UNII-5W827M159J; CHEBI:10106; HSDB 4208; NCI-C50226; C18H22O5; EINECS 241-864-0; (3S,11E)-14,16-dihydroxy-3-methyl-3,4,5,6,9,10-hexahydro-1H-2-benzoxacyclotetradecine-1,7(8H)-dione; 6-(10-Hydroxy-6-oxo-trans-1-undecenyl)-beta-resorcylic acid lactone; BRN 1350216; MLS000097901; CHEMBL454173; MBMQEIFVQACCCH-QBODLPLBSA-N; 5W827M159J; (S-(E))-3,4,5,6,9,10-Hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione; 1H-2-Benzoxacyclotetradecin-1,7(8H)-dione, 3,4,5,6,9,10-hexahydro-14,16-dihydroxy-3-methyl-, (3S,11E)-; SMR000058177; DSSTox_CID_1460; Benzoxacyclotetradec-11-en-1-one, 14,16-dihydroxy-3-methyl-7-oxo-, trans-; Resorcylic acid, 6-(10-hydroxy-6-oxo-1-undecenyl)-, mu-lactone, trans-; DSSTox_RID_76167; DSSTox_GSID_21460; (2E,11S)-15,17-dihydroxy-11-methyl-12-oxabicyclo[12.4.0]octadeca-1(14),2,15,17-tetraene-7,13-dione; 1H-2-Benzoxacyclotetradecin-1,7(8H)-dione, 3,4,5,6,9,10-hexahydro-14,16-dihydroxy-3-methyl-, (S)-(-)-; fusarium toxin; [S-(E)]-3,4,5,6,9,10-hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione; Zearalenone 100 microg/mL in Acetonitrile; CAS-17924-92-4; (S,E)-14,16-Dihydroxy-3-methyl-3,4,5,6,9,10-hexahydro-1H-benzo[c][1]oxacyclotetradecine-1,7(8H)-dione; 1H-2-Benzoxacyclotetradecin-1,7(8H)-dione, 3,4,5,6,9,10-hexahydro-14,16-dihydroxy-3-methyl-, (S-(E))-; benzoxacyclotetradecin-1,7(8H)-dione; ntoxin f2; ZEA; (S)-Zear alenone; Compound F-2; Opera_ID_1608; Epitope ID:146094; SCHEMBL33754; SCHEMBL33755; BSPBio_003581; Zearalenone, fungal mycotoxin; MLS000028817; MLS000888273; MLS001174881; BIDD:ER0058; SPECTRUM1505290; Zearalenone, reference material; fermentation estrogenic substance; 6-(10-Hydroxy-6-oxo-trans-1-undecenyl)-.beta.-resorcylic acid lactone; DTXSID0021460; REGID_for_CID_657988; REGID_for_CID_5281576; (E)-3,4,5,6,7,8,9,10-Octahydro-14,16-dihydroxy-3-methyl-7-oxo-1H-2-benzoxacyclotetradecin-1-one; 1H-2-Benzoxacyclotetradecin-1-one, 3,4,5,6,7,8,9,10-octahydro-14,16-dihydroxy-3-methyl-7-oxo-, (E)-; ALBB-030793; BCP06062; ZINC3881412; Tox21_201153; Tox21_303510; BBL010576; BDBM50247676; CCG-40041; LMPK04000016; LS-946; MFCD00133085; s5676; STK033813; AKOS001577898; QC-9992; SDCCGMLS-0066858.P001; NCGC00038520-03; NCGC00090809-01; NCGC00090809-02; NCGC00257246-01; NCGC00258705-01; (2E,11S)-15,17-dihydroxy-11-methyl-12-oxabicyclo[12.4.0]octadeca-1(18),2,14,16-tetraene-7,13-dione; (3S,11E)-3,4,5,6,9,10-Hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione; (S-(Z))-3,4,5,6,9,10-Hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione; 1H-2-Benzoxacyclotetradecin-1,7(8H)-dione, 3,4,5,6,9,10-hexahydro-14,16-dihydroxy-3-methyl-, (S-(Z))-; 36455-70-6; VS-02573; HY-103447; B7556; CS-0027914; C09981; 924Z924; Q169326; Zearalenone Ready Made Solution, 1 mg/mL in DMSO; J-011439; BRD-K42017082-001-02-6; trans-6-(10-hydroxy-6-oxo-1-undecenyl)resorcylic acid mu-lactone; 6-(10-hydroxy-6-oxo-trans-1-undecenyl)-beta-resorcylic acid N-lactone; trans-14,16-dihydroxy-3-methyl-7-oxobenzoxacyclotetradec-11-en-1-one; Zearalenone solution, 100 mug/mL in acetonitrile, analytical standard; (-)-(3S,11E)-3,4,5,6,9,10-hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1, 7(8H)-dione; (-)-(3S,11E)-3,4,5,6,9,10-hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione; (2E,11S)-15,17-dihydroxy-11-methyl-12-oxabicyclo[12.4.0]octadeca-1(14), 2,15,17-tetraene-7,13-dione; (3S,11E)-14,16-dihydroxy-3-methyl-3,4,5,6,7,8,9,10-octahydro-1H-2-benzoxacyclotetradecine-1,7-dione; (3S,11E)-3,4,5,6,9,10-Hexahydro-14, 16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradecin- 1,7(8H)-dione; (S)-(- )-3,4,5,6,9,10-hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione; (S)-(-)-3,4,5,6,9,10-hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)-dione; 1H-2-Benzoxacyclotetradecin-1,7(8H)-dione, 3,4,5,6,9,10-hexahydro-14,16-dihydroxy-3-methyl-, (3S)-; 2beta-Methyl-15,17-dihydroxy-12,13-butano-1-oxacyclotetradecane-10,15(13),16,18(12)-tetraene-6,14-dione; 3,4,5,6,9,10-hexahydro-14,16-dihydroxy-3-methyl-1H-2-benzoxacyclotetradecin-1,7(8H)dione; Zearalenone solution, certified reference material, 50 mug/mL in acetonitrile, ampule of 1 mL;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C18H22O5",
"molecular_weight": "318.4",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "5281576",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [],
"function": [
"F0108"
],
"references": [
"RC02190",
"RC02811",
"RC03432"
]
},
{
"compound_ID": "D1159",
"name": "2-(Dimethylamino)-1,3-benzothiazol-6-ol",
"synonyms": "943-04-4; 2-(dimethylamino)-1,3-benzothiazol-6-ol; 2-Dimethylamino-benzothiazol-6-ol; 2-(Dimethylamino)benzothiazol-6-ol; 2-Dimethylamino-6-benzothiazolol; 2-(dimethylamino)benzo[d]thiazol-6-ol; F0346-2873; EINECS 213-396-7; 2-Dimethylamino-6-hydroxybenzothiazole; ChemDiv2_000157; EC-000.1449; Polyglutamine Aggregation Inhibitor, PGL-137; Cambridge id 5195231; Oprea1_054529; Oprea1_438603; SCHEMBL5536580; CTK5H6344; DTXSID10241407; PGL-137; HMS1369H03; ZINC274145; ALBB-006152; 3902AF; 6-Benzothiazolol,2-(dimethylamino)-; SBB013391; STK098197; AKOS000541752; CCG-103796; MCULE-1416940758; ST4119496; TR-033381; BB 0260428; FT-0679191; L-3168;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C9H10N2OS",
"molecular_weight": "194.26",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "70339",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01484"
]
},
{
"compound_ID": "D1160",
"name": "4-[(7-Nitro-2,1,3-benzoxadiazol-4-yl)amino]phenol",
"synonyms": "XXPDUJOIUKXXHZ-UHFFFAOYSA-N; 4-[(7-nitro-2,1,3-benzoxadiazol-4-yl)amino]phenol; N-(4-Hydroxyphenyl)-4-amino-7-nitrobenz-2,1,3-oxadiazol; 101237-25-6; SCHEMBL6834736; CHEMBL2312749; ZINC3879012; AKOS000605940; MCULE-3744998117; 4-[(7-Nitrobenzofurazane-4-yl)amino]phenol; EU-0035109; ST50007972; AB00076412-01; SR-01000402766; SR-01000402766-1; 4-[(7-nitrobenzo[2,3-c]1,2,5-oxadiazol-4-yl)amino]phenol;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C12H8N4O4",
"molecular_weight": "272.22",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "3128214",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01485"
]
},
{
"compound_ID": "D1161",
"name": "7,8-Dihydroxy-4-methylcoumarin",
"synonyms": "4-Methyldaphnetin; 7,8-DIHYDROXY-4-METHYLCOUMARIN; 2107-77-9; 7,8-Dihydroxy-4-methyl-2H-chromen-2-one; 4-Methyldaphnetine; 4-Methyl-7,8-dihydroxycoumarin; 2H-1-Benzopyran-2-one, 7,8-dihydroxy-4-methyl-; Coumarin, 7,8-dihydroxy-4-methyl-; 7,8-Dihydroxy-4-methyl-2H-1-benzopyran-2-one; 7,8-dihydroxy-4-methylchromen-2-one; 7,8-Dihydroxy-4-methyl-2-benzopyrone; 7,8-Dihydroxy-4-methyl-chromen-2-one; CHEMBL276618; NSC45795; EINECS 218-290-4; NSC 45795; NSC 72276; BRN 0177613; 7,8-dihydroxy-4-methyl-1-benzopyran-2-one; Coumarin,8-dihydroxy-4-methyl-; WLN: T66 BOVJ E1 IQ JQ; 2H-1-Benzopyran-2-one,8-dihydroxy-4-methyl-; SR-01000480657; DHMC; ACMC-20alxk; Spectrum_001033; SpecPlus_000497; Spectrum2_000321; Spectrum3_000596; Spectrum4_001721; Spectrum5_000482; Oprea1_604916; BSPBio_002072; KBioGR_002102; KBioSS_001513; MLS002207178; DivK1c_006593; SPECTRUM1500730; SPBio_000321; SCHEMBL1065373; 7-8-dihydroxy-4-methylcoumarin; CTK4E5821; KBio1_001537; KBio2_001513; KBio2_004081; KBio2_006649; KBio3_001572; ZINC58124; DTXSID30175295; CHEBI:107667; NWQBYMPNIJXFNQ-UHFFFAOYSA-N; ALBB-024843; BB_NC-01804; HY-N4286; KS-000017NY; NSC72276; ZX-AN023357; BBL027826; BDBM50022184; CCG-38597; MFCD00016972; NSC-45795; NSC-72276; s9000; SBB072361; STK372480; AKOS003239199; FCH1112788; MCULE-3976661039; 7,8-Dihydroxy-4-methylcoumarin, 97%; NCGC00095917-01; NCGC00095917-02; NCGC00178834-01; AK144143; AS-66969; LS-55169; OR345049; SMR001306753; AB0118852; TC-168095; CS-0032640; D4793; FT-0619078; R1342; ST45027977; 7,8-Dihydroxy-4-methyl-2H-chromen-2-one #; 2H-1-Benzopyran-2-one,7,8-dihydroxy-4-methyl-; 5-18-03-00234 (Beilstein Handbook Reference); C-57566; J-013823; SR-01000480657-1; SR-01000480657-2; BRD-K49207204-001-02-9; BRD-K49207204-001-04-5; Q27185989; 2H-1-Benzopyran-2-one, 7,8-dihydroxy-4-methyl- (9CI);",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C10H8O4",
"molecular_weight": "192.17",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "5355836",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01486"
]
},
{
"compound_ID": "D1162",
"name": "4-Amino-2-(5-ethyl-benzooxazol-2-yl)-phenol",
"synonyms": "4-Amino-2-(5-ethyl-benzooxazol-2-yl)-phenol; 4-amino-2-(5-ethyl-1,3-benzoxazol-2-yl)phenol; SMR000012129; MLS000030589; 350477-10-0; 4-amino-2-(5-ethylbenzo[d]oxazol-2-yl)phenol; Oprea1_460903; Oprea1_534246; SCHEMBL2244685; CHEMBL1468497; BDBM38862; cid_5408882; HMS2175E22; BBL002663; STK040297; ZINC13126560; AKOS000108880; MCULE-8015021258; (6E)-4-amino-6-(5-ethyl-3H-1,3-benzoxazol-2-ylidene)cyclohexa-2,4-dien-1-one; VS-01154; 4-amino-2-(5-ethylbenzoxazol-2-yl)phenol; BB 0245408; ST50271093; T8901; SR-01000315189; SR-01000315189-1; (6E)-4-amino-6-(5-ethyl-3H-1,3-benzoxazol-2-ylidene)-1-cyclohexa-2,4-dienone; (6E)-4-azanyl-6-(5-ethyl-3H-1,3-benzoxazol-2-ylidene)cyclohexa-2,4-dien-1-one;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C15H14N2O2",
"molecular_weight": "254.28",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "653891",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01487"
]
},
{
"compound_ID": "D1163",
"name": "(4-Methoxyphenyl)-[2-(p-anisidino)ethyl]amine",
"synonyms": "SMR000102471; MLS000105590; (4-Methoxyphenyl){2-[(4-methoxyphenyl)amino]ethyl}amine; Cambridge id 5174308; CBDivE_012642; SCHEMBL1030950; CHEMBL1500181; BDBM42974; cid_1809552; HMS2391P16; di(4 methoxylphenyl)ethylenediamine; ZINC2165689; N,N'-Ethylenebis(4-methoxyaniline); MCULE-5067523920; (4-methoxyphenyl)-[2-(p-anisidino)ethyl]amine; N,N''-bis(4-methoxyphenyl)ethane-1,2-diamine; N1,N2-BIS(4-METHOXYPHENYL)ETHANE-1,2-DIAMINE; MESO-1,2-BIS(4-METHOXYPHENYL)ETHYLENE-DI AMINE;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C16H20N2O2",
"molecular_weight": "272.34",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "1809552",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01488"
]
},
{
"compound_ID": "D1164",
"name": "3,3'-Diamino-4,4'-dihydroxydiphenyl Sulfone",
"synonyms": "7545-50-8; 3,3'-Diamino-4,4'-dihydroxydiphenyl Sulfone; 4,4'-Sulfonylbis(2-aminophenol); Bis(3-amino-4-hydroxyphenyl) Sulfone; 4,4'-Sulphonylbis(2-aminophenol); 2-amino-4-[(3-amino-4-hydroxyphenyl)sulfonyl]phenol; 4,4'-sulphonylbis[2-aminophenol]; Bis(3-amino-4-hydroxyphenyl)sulfone; NSC155173; Phenol, 4,4'-sulfonylbis[2-amino-; 3-amino-4-hydroxyphenyl sulfone; AK-50096; 3,3-Diamino-4,4-Dihydroxydiphenyl Sulfone; EINECS 231-428-8; ACMC-209oyf; Cambridge id 5105145; Oprea1_144507; Oprea1_606502; CBDivE_002025; MLS000673851; SCHEMBL109925; 2-amino-4-(3-amino-4-hydroxybenzenesulfonyl)phenol; ARONIS016718; CHEMBL1566370; CTK5E1581; KS-00000NCG; ZINC36432; DTXSID40226383; KECOIASOKMSRFT-UHFFFAOYSA-N; HMS2774C03; 3-Amino-?4-?hydroxyphenyl Sulfone; ACT07462; ALBB-006612; ZX-AN006271; Phenol,4,4'-sulfonylbis[2-amino-; ANW-36613; STK025810; 2,2'-Diamino-4,4'-sulfonyldiphenol; AKOS000266219; MCULE-1716090328; NSC-155173; RTR-024267; VZ26238; KS-000049B8; NCGC00245961-01; DS-15330; SC-24886; SMR000315092; ST052014; AB0066244; AX8081291; BB0272992; DB-055959; TR-024267; B2859; EU-0099868; FT-0081676; R1542; ST24041086; Z5558; 545D508; C-17635; 2-amino-4-(3-amino-4-hydroxy-phenyl)sulfonyl-phenol; 2-AMINO-4-[(3-AMINO-4-HYDROXYPHENYL)-SULFONYL]PHENOL;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C12H12N2O4S",
"molecular_weight": "280.3",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "82047",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01489"
]
},
{
"compound_ID": "D1165",
"name": "2-(4-Hydroxy-1H-indol-3-yl)acetamide",
"synonyms": "2-(4-hydroxy-1H-indol-3-yl)acetamide; SMR000068939; MLS000052983; 4-hydroxy-1H-Indole-3-acetamide; Cambridge id 5106694; Oprea1_492111; CBDivE_002318; SCHEMBL1395836; CHEMBL1522203; BDBM49136; cid_2053734; HMS2371J22; 2-(4-hydroxyindol-3-yl)acetamide; ZINC2464568; STK386805; AKOS001586358; MCULE-9143898485; 2-(4-oxidanyl-1H-indol-3-yl)ethanamide; ST50894410; SR-01000388255; SR-01000388255-1;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C10H10N2O2",
"molecular_weight": "190.2",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "2053734",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01490"
]
},
{
"compound_ID": "D1166",
"name": "2,5-Bis(2-phenylacetamido)terephthalic acid",
"synonyms": "CHEMBL198442; 2,5-bis(2-phenylacetamido)terephthalic acid; 1,4-Benzenedicarboxylic acid, 2,5-bis[(phenylacetyl)amino]-; 339157-51-6; CBDivE_010581; Cambridge id 5181020; 2,5-bis[(2-phenylacetyl)amino]terephthalic acid; Oprea1_095367; SCHEMBL3502924; CTK1B8093; DTXSID00360015; ZINC9310951; BDBM50178723; STL328777; AKOS022139579; MCULE-8085808164; SR-01000197753; SR-01000197753-1; 2,5-bis[(phenylacetyl)amino]benzene-1,4-dicarboxylic acid;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C24H20N2O6",
"molecular_weight": "432.4",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "1067769",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01491"
]
},
{
"compound_ID": "D1167",
"name": "2,6-Dimethyl-5,12-dihydroindolo[3,2-d][1,3]benzodiazepine;hydrochloride",
"synonyms": "Cambridge id 5219818;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C17H16ClN3",
"molecular_weight": "297.8",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "2834670",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01492"
]
},
{
"compound_ID": "D1168",
"name": "N-(4-{[(4,6-Dimethyl-2-pyrimidinyl)amino]sulfonyl}phenyl)-2,4-dimethoxybenzamide",
"synonyms": "Cambridge id 5219504; Oprea1_176516; Oprea1_623173; CBDivE_007468; ZINC786524; AKOS002345709; MCULE-6130883208; AB00075658-01; AO-854/40185583; N-(4-{[(4,6-dimethyl-2-pyrimidinyl)amino]sulfonyl}phenyl)-2,4-dimethoxybenzamide;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C21H22N4O5S",
"molecular_weight": "442.5",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "1076765",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01493"
]
},
{
"compound_ID": "D1169",
"name": "N'-(4-Methoxybenzyl)-N,N-dimethylbenzene-1,3-diamine",
"synonyms": "N'-(4-methoxybenzyl)-N,N-dimethylbenzene-1,3-diamine; 415960-38-2; Cambridge id 5452512; Oprea1_558877; SCHEMBL13479676; ZINC279506; ALBB-028972; ZX-AN079785; STL429955; AKOS019066784; AB00085453-01; SR-01000209290; SR-01000209290-1; 1,3-Benzenediamine, N'-[(4-methoxyphenyl)methyl]-N,N-dimethyl-;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C16H20N2O",
"molecular_weight": "256.34",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "783792",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01494"
]
},
{
"compound_ID": "D1170",
"name": "4-(1,2,3,4-Tetrahydro-benzo[a]phenanthridin-5-yl)-benzene-1,2-diol",
"synonyms": "Oprea1_173902; Oprea1_441282; ZINC275239; 4-(1,2,3,4-Tetrahydro-benzo[a]phenanthridin-5-yl)-benzene-1,2-diol; AKOS000669128; MCULE-3895443298; EU-0000859;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C23H19NO2",
"molecular_weight": "341.4",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "781103",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01495"
]
},
{
"compound_ID": "D1171",
"name": "N-Benzyl-4-methoxyaniline",
"synonyms": "N-Benzyl-4-methoxyaniline; 17377-95-6; N-Benzyl-p-anisidine; LIJJGMDKVVOEFT-UHFFFAOYSA-N; (4-methoxyphenyl)benzylamine; N-(4-methoxyphenyl)-N-benzylamine; N-Benzyl-4-anisidine; N-benzyl-para-anisidine; ACMC-1BVSM; N-benzyl-p-methoxyaniline; Cambridge id 5107549; N-benzyl-4-methoxy-aniline; Oprea1_078973; N-(4-methoxyphenyl)benzylamine; CHEMBL237233; SCHEMBL1757104; CTK3J3047; N-(4-methoxyphenyl)benzyl amine; Benzyl-(4-methoxy-phenyl)-amine; DTXSID50334009; HMS1577N01; KS-000017EY; N-Benzyl-N-(4-methoxyphenyl)amine; ZINC2464595; ANW-22677; MFCD00059298; SBB073018; STK874207; AKOS000121242; N-Benzyl-N-(4-methoxyphenyl)amine #; CB-1790; MCULE-1541344594; NE19943; UPCMLD0ENAT5666665:001; NCGC00338172-01; 11J-507S; Benzenemethanamine, N-(4-methoxyphenyl)-; RT-001219; B0409; FT-0768413; ST45208532; AB00274972-04;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C14H15NO",
"molecular_weight": "213.27",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "519413",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01496"
]
},
{
"compound_ID": "D1172",
"name": "Methyl 2-amino-4-ethyl-5-methylthiophene-3-carboxylate",
"synonyms": "methyl 2-amino-4-ethyl-5-methylthiophene-3-carboxylate; 4815-25-2; 2-amino-4-ethyl-5-methylthiophene-3-carboxylic acid methyl ester; 2-Amino-4-ethyl-5-methyl-thiophene-3-carboxylic acid methyl ester; PubChem5225; Oprea1_184738; SCHEMBL8907220; CTK4J0686; KS-00003KCW; DTXSID30344525; ODDNCALHGKYZJB-UHFFFAOYSA-N; ZINC439063; ALBB-001581; BBL037367; SBB019601; STK315360; AKOS000220119; FS-1355; MCULE-1487722130; QC-6102; AB0096491; DB-029284; TR-051824; FT-0693519; ST45138850; Z3231; W-7594; Methyl 2-amino-4-ethyl-5-methyl-3-thiophenecarboxylate; Methyl 2-amino-4-ethyl-5-methyl-3-thiophenecarboxylate #; 2-Amino-4-ethyl-5-methyl-thiophene-3-carboxylicacid methyl ester; 3-Thiophenecarboxylicacid, 2-amino-4-ethyl-5-methyl-, methyl ester;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C9H13NO2S",
"molecular_weight": "199.27",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "597615",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01497"
]
},
{
"compound_ID": "D1173",
"name": "N-(4-(4-Methyl-1-piperazinyl)phenyl)-9-acridinamine",
"synonyms": "80259-18-3; GNF-PF-3427; TCMDC-123912; JP 1302; JP-1302; BRN 5117597; N-(4-(4-Methyl-1-piperazinyl)phenyl)-9-acridinamine; MMV006172; N-[4-(4-methylpiperazin-1-yl)phenyl]acridin-9-amine; CHEMBL106525; QZKGUNQLVFEEBA-UHFFFAOYSA-N; 9-Acridinamine, N-(4-(4-methyl-1-piperazinyl)phenyl)-; N-(4-(4-methylpiperazin-1-yl)phenyl)acridin-9-amine; Acridin-9-yl-[4-(4-methyl-piperazin-1-yl)-phenyl]-amine; N-[4-(4-Methyl-1-piperazinyl)phenyl]-9-acridinamine; 9-Acridinamine, N-[4-(4-methyl-1-piperazinyl)phenyl]-; JP1302; N-[4-(4-Methyl-1-piperazinyl)phenyl]-9-acridinamine dihydrochloride; CBDivE_004989; GTPL3930; SCHEMBL1664525; CTK3E9379; DTXSID70230190; HMS3428A01; HMS3742A17; HMS3745E15; BCP29870; ZINC3878361; BDBM50196135; STK746950; AKOS001483137; JP1302;JP 1302; MCULE-7136386218; NCGC00167823-01; NCGC00167823-02; NCGC00167823-03; LS-14147; ST4002429; acridin-9-yl[4-(4-methylpiperazinyl)phenyl]amine; N-[4-(4-Methylpiperazino)phenyl]acridine-9-amine; Acridin-9-yl-[4-(4-methylpiperazin-1-yl)-phenyl]amine; Acridine, 9-[4-(4-methylpiperazin-1-yl)phenylamino]-; Acridin-9-yl-[4-(4-methylpiperazin-1 -yl)-phenyl]amine;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C24H24N4",
"molecular_weight": "368.5",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "540335",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01498"
]
},
{
"compound_ID": "D1174",
"name": "4-Chloro-N-(2-hydroxyphenyl)benzenesulfonamide",
"synonyms": "4-chloro-N-(2-hydroxyphenyl)benzenesulfonamide; CBDivE_012094; SCHEMBL3260803; UTNJRYLWJOXNFX-UHFFFAOYSA-N; ZINC288815; STK951108; AKOS002248584; MCULE-6583659788; ST50209835; N-(2-hydroxyphenyl)-4-chlorobenzenesulfonamide; [(4-chlorophenyl)sulfonyl](2-hydroxyphenyl)amine;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C12H10ClNO3S",
"molecular_weight": "283.73",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "789223",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01499"
]
},
{
"compound_ID": "D1175",
"name": "N-(4-Hydroxyphenyl)furan-2-carboxamide",
"synonyms": "Furan-2-carboxylic acid (4-hydroxy-phenyl)-amide; N-(4-hydroxyphenyl)furan-2-carboxamide; 4104-33-0; N-(4-hydroxyphenyl)-2-furamide; Cambridge id 5471987; Oprea1_431396; SCHEMBL6637453; CTK4I4191; DTXSID90353678; DGVKXCATWIGAIF-UHFFFAOYSA-N; ZINC193543; STK032597; AKOS000603489; MCULE-2894052001; NE37460; 2-furyl-N-(4-hydroxyphenyl)carboxamide; N-(4-Hydroxyphenyl)-2-furancarboxamide; ST50024793; EN300-06629; AB00086167-01; Furan-2-carboxylic acid(4-hydroxy-phenyl)-amide; AG-690/12868646; SR-01000481288; SR-01000481288-1; Z56943555; F1153-0320; furan-2-carboxylic acid (4-hydroxy-phenyl)-amide, AldrichCPR;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C11H9NO3",
"molecular_weight": "203.19",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "747955",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01500"
]
},
{
"compound_ID": "D1176",
"name": "(Z)-2-Cyano-3-(3-ethoxy-4-hydroxyphenyl)prop-2-enamide",
"synonyms": "CAA102679; ZINC12366726; SR-01000196793; SR-01000196793-1; (2Z)-2-CYANO-3-(3-ETHOXY-4-HYDROXYPHENYL)PROP-2-ENAMIDE;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C12H12N2O3",
"molecular_weight": "232.23",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "736724",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01501"
]
},
{
"compound_ID": "D1177",
"name": "(3-Bromo-4-hydroxyphenyl)[(4-chlorophenyl)sulfonyl]amine",
"synonyms": "CHEMBL3416549; Cambridge id 5158529; ZINC762987; BDBM50076489; AKOS002306612; MCULE-8857982962; ST50774395; AB00074689-01; SR-01000197316; SR-01000197316-1; (3-bromo-4-hydroxyphenyl)[(4-chlorophenyl)sulfonyl]amine;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C12H9BrClNO3S",
"molecular_weight": "362.63",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "1070505",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01502"
]
},
{
"compound_ID": "D1178",
"name": "2-Chloro-6-methylindolo[1,2-c]quinazolin-12-amine",
"synonyms": "2-chloro-6-methylindolo[1,2-c]quinazolin-12-amine; Cambridge id 5219795; Oprea1_380698; Oprea1_848312; CBDivE_008819; 2-Chloro-6-methyl-indolo[1,2-c]quinazolin-12-ylamine; ZINC235485; STL328466; AKOS000558167; MCULE-9509284061; SR-01000454930; SR-01000454930-1;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C16H12ClN3",
"molecular_weight": "281.74",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "762539",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01503"
]
},
{
"compound_ID": "D1179",
"name": "4-(2,3-Dihydro-1H-benzo[f]cyclopenta[c]quinolin-4-yl)benzene-1,2-diol",
"synonyms": "MLS000595076; SMR000184811; 4-(2,3-dihydro-1H-benzo[f]cyclopenta[c]quinolin-4-yl)benzene-1,2-diol; 4-(2,3-dihydro-1H-benzo[f]cyclopenta[c]quinolin-4-yl)-1,2-benzenediol; Oprea1_231130; CHEMBL1560628; SCHEMBL14907850; BDBM46291; cid_5718744; BDBM375043; HMS2533O17; STK369748; ZINC13125138; AKOS001578195; US10252984, Table 2.4; MCULE-6073126280; ST50907207; 4-(1,2,3-trihydrobenzo[f]cyclopenta[2,1-c]quinolin-4-yl)benzene-1,2-diol;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C22H17NO2",
"molecular_weight": "327.4",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "781102",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01504"
]
},
{
"compound_ID": "D1180",
"name": "(5E)-5-(4-Hydroxybenzylidene)-2-mercapto-1,3-thiazol-4(5H)-one",
"synonyms": "81154-13-4; (5E)-5-(4-hydroxybenzylidene)-2-mercapto-1,3-thiazol-4(5H)-one; C10H7NO2S2; (5E)-5-(4-hydroxybenzylidene)-2-thioxo-1,3-thiazolidin-4-one; 5-[(4-hydroxyphenyl)methylene]-2-thioxo-1,3-thiazolidin-4-one; (E)-5-(4-Hydroxybenzylidene)-2-mercaptothiazol-4(5H)-one; AKOS B018312; 81154-14-5; ALBB-009169; ZX-AN008064; ZX-CM001436; 0033AF; STK723317; ZINC15933443; AKOS000307415; AKOS000631612; ST005126; TR-025558; Y-1473; AB00075917-01; 2-Thioxo-5-(4-hydroxybenzylidene)thiazolidine-4-one; (E,Z)-5-(4-hydroxyphenylmethylene)-4-oxo-2-thioxothiazolidine; 4-Thiazolidinone, 5-[(4-hydroxyphenyl)methylene]-2-thioxo-; (5E)-5-[(4-hydroxyphenyl)methylene]-2-thioxo-thiazolidin-4-one; 4-Thiazolidinone, 5-[(4-hydroxyphenyl)methylene]-2-thioxo-, (5E)-; 4-THIAZOLIDINONE,5-[(4-HYDROXYPHENYL)METHYLENE]-2-THIOXO-;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C10H7NO2S2",
"molecular_weight": "237.3",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "1241130",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01505"
]
},
{
"compound_ID": "D1181",
"name": "8-Chloro-2,2-dimethyl-2,3-dihydro-1H-phenothiazin-4(10H)-one",
"synonyms": "8-chloro-2,2-dimethyl-2,3-dihydro-1H-phenothiazin-4(10H)-one; Kinome_3441; Cambridge id 5219661; Oprea1_797658; CBDivE_009145; MLS001030194; CHEMBL1562756; HMS2801I09; ZINC786525; STK837251; AKOS001642869; MCULE-2361032864; SMR000425567; AH-262/31834028; SR-01000484069; SR-01000484069-1; 8-Chloro-2,2-dimethyl-2,3-dihydro-1H,10H-phenothiazin-4-one;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C14H14ClNOS",
"molecular_weight": "279.8",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "741186",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01506"
]
},
{
"compound_ID": "D1182",
"name": "2-[(3,4-Dimethylphenyl)sulfonyl]benzene-1,4-diol",
"synonyms": "2-[(3,4-Dimethylphenyl)sulfonyl]-1,4-benzenediol; Cambridge id 5210729; Oprea1_836039; CBDivE_005174; MLS000685543; CHEMBL1527937; HMS1609A05; HMS2618M06; MCULE-4262267482; SMR000312507; AB00075214-01; 2,5-Dihydroxy-3',4'-dimethyl[sulfonylbisbenzene]; 2-[(3,4-dimethylphenyl)sulfonyl]benzene-1,4-diol;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C14H14O4S",
"molecular_weight": "278.33",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "773181",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01507"
]
},
{
"compound_ID": "D1183",
"name": "4-([4-(1H-Benzimidazol-2-yl)phenyl]amino)-4-oxobutanoic acid",
"synonyms": "27031-00-1; 4-([4-(1H-Benzimidazol-2-yl)phenyl]amino)-4-oxobutanoic acid; 4-{[4-(1H-benzimidazol-2-yl)phenyl]amino}-4-oxobutanoic acid; Cambridge id 5224148; Oprea1_097615; Oprea1_468828; CBDivE_010947; CHEMBL3344006; SCHEMBL15702637; ZINC246361; ALBB-028944; STK017597; AKOS003241800; MCULE-5906775479; AB00075796-01; butanoic acid, 4-[[4-(1H-benzimidazol-2-yl)phenyl]amino]-4-oxo-;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C17H15N3O3",
"molecular_weight": "309.32",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "767937",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01508"
]
},
{
"compound_ID": "D1184",
"name": "Ethyl 2-ethoxy-5-hydroxy-1H-indole-3-carboxylate",
"synonyms": "ethyl 2-ethoxy-5-hydroxy-1H-indole-3-carboxylate; 66866-41-9; Oprea1_088455; CBDivE_004244; MLS000530456; CHEMBL379952; CTK8J9429; DTXSID00354974; HMS1579C05; HMS2358B23; ZINC287001; STL297952; AKOS022108518; MCULE-1979425611; SMR000135434; AB00075667-01; SR-01000199136; SR-01000199136-1; 2-Ethoxy-5-hydroxy-1H-indole-3-carboxylic acid ethyl ester;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C13H15NO4",
"molecular_weight": "249.26",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "788121",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01509"
]
},
{
"compound_ID": "D1185",
"name": "4-(1,2,3,4-Tetrahydrobenzo[a]phenanthridin-5-yl)benzene-1,3-diol",
"synonyms": "NSC698408; Oprea1_372174; CHEMBL1997430; ZINC218776; MCULE-5203738744; NSC-698408; NCI60_035261;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C23H19NO2",
"molecular_weight": "341.4",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "394740",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01510"
]
},
{
"compound_ID": "D1186",
"name": "N-(Cyclohexylmethyl)-4-methoxyaniline",
"synonyms": "N-(cyclohexylmethyl)-4-methoxyaniline; Cambridge id 5454631; N-(CYCLOHEXYLMETHYL)-4-METHOXYBENZENAMINE; Oprea1_300413; SCHEMBL15325738; ZINC279740; AKOS000241701; MCULE-6679037847; 6709-45-1; SC-41007; AB00085532-01;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C14H21NO",
"molecular_weight": "219.32",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "783964",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01511"
]
},
{
"compound_ID": "D1187",
"name": "N-(Furan-2-ylmethyl)-1,3-benzodioxol-5-amine",
"synonyms": "Cambridge id 5457094; Oprea1_271119; SCHEMBL5604995; LEFBIPRUKQBNJF-UHFFFAOYSA-N; ZINC279927; AKOS000245413; N-Furfuryl-1,3-benzodioxole-5-amine; MCULE-1709831194; 3,4-(Methylenedioxy)-N-furfurylaniline; J3.660.998B; AB00085605-01; SR-01000209430; SR-01000209430-1;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C12H11NO3",
"molecular_weight": "217.22",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "784117",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01512"
]
},
{
"compound_ID": "D1188",
"name": "5-Nitro-2-phenyl-1H-indole",
"synonyms": "5-Nitro-2-phenyl-1H-indole; 4993-87-7; INF-55; 5-nitro-2-phenylindole; NSC131894; 2-phenyl-5-nitroindole; Cambridge id 5107950; CBDivE_002236; 2-phenyl-5-nitro-1H-indole; CHEMBL469266; SCHEMBL1465536; CTK1D7091; ZINC24246; DTXSID20299656; UNJRQDPTLDVHOR-UHFFFAOYSA-N; AKOS000507579; MCULE-7961551006; NSC-131894; AB00073850-01;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C14H10N2O2",
"molecular_weight": "238.24",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "280309",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01513"
]
},
{
"compound_ID": "D1189",
"name": "8-Chloro-2,3-dihydro-1H-phenothiazin-4(10H)-one",
"synonyms": "8-chloro-2,3-dihydro-1H-phenothiazin-4(10H)-one; 8-chloro-2,3-dihydro-1H-phenothiazin-4-ol; Oprea1_839073; CBDivE_009253; CHEMBL1422203; HMS2790C21; ZINC287009; STL057475; AKOS005710048; AKOS032390075; ZINC100647699; MCULE-1284844537; AH-262/32928006; SR-01000199139; SR-01000199139-1; 352549-86-1;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C12H10ClNOS",
"molecular_weight": "251.73",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "762523",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01514"
]
},
{
"compound_ID": "D1190",
"name": "N-(4-Bromophenyl)-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine",
"synonyms": "CBDivE_016308; Oprea1_108333;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C13H13BrN2S",
"molecular_weight": "309.23",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "963458",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01515"
]
},
{
"compound_ID": "D1191",
"name": "2-[2-(2-Aminophenyl)vinyl]-5,7-dimethylquinolin-8-ol",
"synonyms": "1321974-20-2; 2-[2-(2-Aminophenyl)vinyl]-5,7-dimethylquinolin-8-ol; SCHEMBL16211085; ALBB-027832; ZX-AN052085; ZINC16667061; AKOS001484880; SR-01000402506; SR-01000402506-1; 2-[(E)-2-(2-aminophenyl)vinyl]-5,7-dimethylquinolin-8-ol; 8-quinolinol, 2-[(E)-2-(2-aminophenyl)ethenyl]-5,7-dimethyl-;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C19H18N2O",
"molecular_weight": "290.4",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "5722157",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01516"
]
},
{
"compound_ID": "D1192",
"name": "4,6-Dimethyl-2-phenyl-2H-pyrazolo[3,4-b]pyridin-3-ol",
"synonyms": "4,6-Dimethyl-2-phenyl-2H-pyrazolo[3,4-b]pyridin-3-ol; 4,6-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazolo[3,4-b]pyridin-3-one; ChemDiv2_000731; ChemDiv3_009260; Oprea1_701343; Oprea1_777478; Oprea1_790900; CBDivE_001977; MLS000052961; CHEMBL3144916; HIXUVUJDKKNNGA-UHFFFAOYSA-N; HMS1371B05; HMS1499E20; HMS2384N22; ZINC173061; STK026219; STK328060; AKOS000546175; AKOS003264393; ZINC100137725; CCG-131425; MCULE-3334446453; IDI1_027170; SMR000068918; ST4083221; 4,6-dimethyl-2-phenylpyrazolo[3,4-b]pyridin-3-ol; 2H-Pyrazolo[3,4-b]pyridin-3-ol, 4,6-dimethyl-2-phenyl-; 2-Phenyl-4,6-dimethyl-1H-pyrazolo[3,4-b]pyridine-3(2H)-one;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C14H13N3O",
"molecular_weight": "239.27",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "712750",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01517"
]
},
{
"compound_ID": "D1193",
"name": "4-Methoxy-2-[(4-piperidylpiperidyl)methyl]phenol",
"synonyms": "Cambridge id 5410291; Oprea1_396511; Oprea1_857985; ZINC243762; AKOS000553671; MCULE-7227925304; ST45158829; AB00084311-01; 4-methoxy-2-[(4-piperidylpiperidyl)methyl]phenol;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C18H28N2O2",
"molecular_weight": "304.4",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "766835",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01518"
]
},
{
"compound_ID": "D1194",
"name": "N-(5-Isopropyl-1,3,4-thiadiazol-2-yl)-3-nitrobenzamide",
"synonyms": "N-(5-isopropyl-1,3,4-thiadiazol-2-yl)-3-nitrobenzamide; Cambridge id 5210298; Oprea1_660133; CBDivE_005019; ZINC34695; STK720064; AKOS001428755; MCULE-8481477097; ST050336; EU-0067947; AB00075184-01; SR-01000395112; SR-01000395112-1; 3-nitro-N-[5-(propan-2-yl)-1,3,4-thiadiazol-2-yl]benzamide; N-[5-(methylethyl)(1,3,4-thiadiazol-2-yl)](3-nitrophenyl)carboxamide;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C12H12N4O3S",
"molecular_weight": "292.32",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "672835",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01519"
]
},
{
"compound_ID": "D1195",
"name": "2-Amino-6-ethyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide",
"synonyms": "2-amino-6-ethyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxamide; 328270-02-6; 2-amino-6-ethyl-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxamide; 2-Amino-6-ethyl-4,5,6,7-tetrahydro-benzo[b]thiophene-3-carboxylic acid amide; MLS000526235; Oprea1_318528; Oprea1_409133; SCHEMBL1067537; CHEMBL1632449; CTK6D1921; HMS2507M09; ALBB-001602; ZX-AN001586; BBL016127; SBB009179; STK348708; AKOS000141876; AKOS016344993; MCULE-1586726280; SMR000116709; VS-05157; TR-051835; EN300-31864; Z-0602; AK-968/11843108; 2-Amino-6-ethyl-4,5,6,7-tetrahydro benzo[b]thiophene-3-carboxylic acid amide; 2-amino-6-ethyl-4,5,6,7-tetrahydro-benzo[b]thiophene-3-carboxylic acid amide, AldrichCPR; 2-amino-6-ethyl-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic acid amide;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C11H16N2OS",
"molecular_weight": "224.32",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "2861874",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01520"
]
},
{
"compound_ID": "D1196",
"name": "(NE)-N-[[3-[[3-[(E)-hydroxyiminomethyl]-2,4,6-trimethylphenyl]methyl]-2,4,6-trimethylphenyl]methylidene]hydroxylamine",
"synonyms": "AKOS000505571; ST50000072; (hydroxyimino)(3-{[3-((hydroxyimino)methyl)-2,4,6-trimethylphenyl]methyl}-2,4, 6-trimethylphenyl)methane;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C21H26N2O2",
"molecular_weight": "338.4",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "6891477",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01521"
]
},
{
"compound_ID": "D1197",
"name": "N-(3-Fluorophenyl)-2,4,6-tri(propan-2-yl)benzenesulfonamide",
"synonyms": "Oprea1_183090; Oprea1_760196; SCHEMBL15761598; ZINC752176; MCULE-1182817351;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C21H28FNO2S",
"molecular_weight": "377.5",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "1067819",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01522"
]
},
{
"compound_ID": "D1198",
"name": "2-(4-Hydroxy-3-methoxybenzylidene)-1H-indene-1,3(2H)-dione",
"synonyms": "58161-73-2; 2-(4-hydroxy-3-methoxybenzylidene)-1H-indene-1,3(2H)-dione; 2-[(4-hydroxy-3-methoxyphenyl)methylene]cyclopenta[1,2-a]benzene-1,3-dione; CBDivE_015324; MLS000776912; CHEMBL1341388; ZINC76005; HMS2766H13; 2-[(4-hydroxy-3-methoxyphenyl)methylene]-1H-Indene-1,3(2H)-dione; BBL005720; SBB043760; STK326990; AKOS000274405; MCULE-2454819166; UPCMLD0ENAT5741030:001; SMR000413310; ST024367; H3195; SR-01000196149; SR-01000196149-1; 2-(4-Hydroxy-3-methoxy-benzylidene)-indan-1,3-dione; Z44300975; 2-[(4-hydroxy-3-methoxyphenyl)methylidene]-2,3-dihydro-1H-indene-1,3-dione;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C17H12O4",
"molecular_weight": "280.27",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "698576",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01523"
]
},
{
"compound_ID": "D1199",
"name": "2-[2-(5-Hydroxy-1H-indol-3-yl)ethyl]-1H-isoindole-1,3(2H)-dione",
"synonyms": "2-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-1H-isoindole-1,3(2H)-dione; 2-(2-(5-hydroxy-1H-indol-3-yl)ethyl)isoindole-1,3-dione; 53157-46-3; ChemDiv2_003209; Cambridge id 5106791; Oprea1_158047; Oprea1_523437; CBDivE_000438; MLS000703291; SCHEMBL2531516; CHEMBL1606430; CTK1G1307; DTXSID60355048; QXPSOWPOHSZKEK-UHFFFAOYSA-N; HMS1378B19; HMS2640H03; ZINC290473; STK028833; AKOS000623773; MCULE-5357903361; SMR000273755; EU-0000224; ST50888660; 5-Hydroxy-3-(2-phthalimidoethyl)-1H-indole; AB00073773-01; AI-981/36563018; SR-01000389832; SR-01000389832-1; 2-[2-(5-hydroxyindol-3-yl)ethyl]benzo[c]azoline-1,3-dione; 1H-Isoindole-1,3(2H)-dione, 2-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C18H14N2O3",
"molecular_weight": "306.3",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "790197",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01524"
]
},
{
"compound_ID": "D1200",
"name": "2-Furancarboxamide, N-[[(4-methoxyphenyl)amino]thioxomethyl]-",
"synonyms": "2-Furancarboxamide, N-[[(4-methoxyphenyl)amino]thioxomethyl]-; 82366-69-6; SCHEMBL14096454; CTK3E0437; DTXSID90385358; ZINC3878495; AKOS000584284; MCULE-4154742507; 1-(2-Furoyl)-3-(4-methoxyphenyl)thiourea;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C13H12N2O3S",
"molecular_weight": "276.31",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "2833088",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01525"
]
},
{
"compound_ID": "D1201",
"name": "2-Amino-N-quinolin-8-yl-benzenesulfonamide",
"synonyms": "2-Amino-N-quinolin-8-yl-benzenesulfonamide; 16082-64-7; CHEMBL256062; QBS; 2-amino-N-(quinolin-8-yl)benzenesulfonamide; Cambridge id 5175136; Oprea1_584159; CBDivE_007127; SCHEMBL460773; CTK4D0607; DTXSID90360049; NIOOKXAMJQVDGB-UHFFFAOYSA-N; ZINC758699; DNDI1417207; BDBM50372507; CCG-15219; MFCD00168987; AKOS000154013; NCGC00161683-01; NCGC00161683-02; NCGC00161683-03; NCGC00161683-04; 2-amino-n-quinoline-8-yl-benzenesulfonamide; 2-AMINO-N-QUINOLINE-8-YL-BENZENESULFONAM; AB00074880-01; 2-AMINO-N-QUINOLINE-8-YLBENZENESULFONAMIDE; CU-00000000193-1; CU-00000000193-2; J-009759; 2-Amino-N-quinolin-8-yl-benzenesulfonamide, >=98% (HPLC), solid;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C15H13N3O2S",
"molecular_weight": "299.3",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "1070159",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01526"
]
},
{
"compound_ID": "D1202",
"name": "(5Z)-5-[(4-Fluorophenyl)methylidene]-1-methyl-3-phenyl-1,3-diazinane-2,4,6-trione",
"synonyms": "SR-01000200503; SR-01000200503-1;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C18H13FN2O3",
"molecular_weight": "324.3",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "2056044",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01527"
]
},
{
"compound_ID": "D1203",
"name": "2-[4-(1-Adamantyl)phenoxy]-N,N-diethylethanamine;hydrochloride",
"synonyms": "Status: 404; Code: PUGREST.NotFound; Message: No synonyms found for the given CID(s);",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C22H34ClNO",
"molecular_weight": "364",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "50944402",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01528"
]
},
{
"compound_ID": "D1204",
"name": "(2Z)-2-(Acetylamino)-N-(4-hydroxyphenyl)-3-phenylprop-2-enamide",
"synonyms": "(2Z)-2-(acetylamino)-N-(4-hydroxyphenyl)-3-phenylprop-2-enamide; MLS000715224; ARONIS018642; CHEMBL1872355; HMS1554H10; HMS2740I15; ZINC4526333; STK041903; AKOS000485325; SMR000275203; ST095028; AB00074571-01; SR-01000507504; SR-01000507504-1; (2Z)-2-(acetylamino)-N-(4-hydroxyphenyl)-3-phenylacrylamide; (Z)-2-(acetylamino)-N~1~-(4-hydroxyphenyl)-3-phenyl-2-propenamide;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C17H16N2O3",
"molecular_weight": "296.32",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "5403184",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01529"
]
},
{
"compound_ID": "D1205",
"name": "(5E)-5-[(3-Bromo-4-methoxyphenyl)methylidene]-1-phenyl-2-sulfanylidene-1,3-diazinane-4,6-dione",
"synonyms": "SCHEMBL15702610;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C18H13BrN2O3S",
"molecular_weight": "417.3",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "1070529",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01530"
]
},
{
"compound_ID": "D1206",
"name": "[(3-{[(4-Bromophenyl)amino]carbonyl}phenyl)thio]acetic acid",
"synonyms": "[(3-{[(4-bromophenyl)amino]carbonyl}phenyl)thio]acetic acid; CBDivE_007237; Cambridge id 5210767; SCHEMBL15702606; ZINC786410; MCULE-8154696202; AB00075217-01; SR-01000198570; SR-01000198570-1;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C15H12BrNO3S",
"molecular_weight": "366.2",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "1076687",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01531"
]
},
{
"compound_ID": "D1207",
"name": "2-[(4-Chlorobenzyl)thio]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole",
"synonyms": "MLS000104679; SMR000054612; 2-[(4-chlorobenzyl)thio]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole; 4-chlorobenzyl 6,7-dihydro-5H-pyrrolo[1,2-a]imidazol-2-yl sulfide; ChemDiv3_002067; CBDivE_008148; cid_759935; CHEMBL1373692; BDBM71854; HMS1478N21; HMS2300H12; ZINC227358; CCG-17905; STK832611; 2-[(4-chlorophenyl)methylsulfanyl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole; AKOS001631811; MCULE-1670952477; IDI1_021033; AB00076341-01; AH-262/34614060; SR-01000454948; SR-01000454948-1; BRD-K22045265-001-01-2; 2-[(4-chlorobenzyl)thio]-6,7-dihydro-5H-pyrrol[1,2-a]imidazole; 2-[(4-chlorobenzyl)sulfanyl]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole; 2-[(4-chlorophenyl)methylthio]-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole; 352553-74-3;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C13H13ClN2S",
"molecular_weight": "264.77",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "759935",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01532"
]
},
{
"compound_ID": "D1208",
"name": "1-(5-Hydroxy-2-methyl-1-phenyl-1H-indol-3-yl)ethanone",
"synonyms": "1-(5-hydroxy-2-methyl-1-phenyl-1H-indol-3-yl)ethanone; 5102-18-1; 1-(5-Hydroxy-2-methyl-1-phenyl-1H-indol-3-yl)-ethanone; 1-(5-hydroxy-2-methyl-1-phenyl-1H-indol-3-yl)ethan-1-one; MLS000060930; Cambridge id 5215317; CBDivE_004326; CHEMBL1324846; SCHEMBL13576515; CTK4J3499; HMS2417N16; KUC106617N; ZINC275502; KSC-09-215F; BBL001817; STK008463; AKOS000520845; MCULE-5675409676; NCGC00056822-03; SMR000069158; VS-00882; 1-Phenyl-2-methyl-3-acetyl-1H-indol-5-ol; 3-acetyl-5-hydroxy-2-methyl-1-phenylindole; BB 0221176; ST45141523; 1-phenyl-2-methyl-3-acetyl-5-hydroxy-indole; W-7309; AB00075497-01; AB00075497-11; AE-907/30536057; F0349-0854;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C17H15NO2",
"molecular_weight": "265.31",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "781247",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01533"
]
},
{
"compound_ID": "D1209",
"name": "2-[(4-Ethylpiperazin-1-yl)methyl]-4-methoxyphenol",
"synonyms": "Oprea1_801250; ZINC22578800; AKOS021294705; MCULE-1048867848; SR-01000208213; 2-[(4-ethyl-1-piperazinyl)methyl]-4-methoxyphenol; SR-01000208213-1;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C14H22N2O2",
"molecular_weight": "250.34",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "782034",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01534"
]
},
{
"compound_ID": "D1210",
"name": "4-(4-Fluorophenyl)-1,3,5-trimethyl-2,6-diphenylpiperidin-4-ol",
"synonyms": "ChemDiv1_019951; Oprea1_236408; Oprea1_384940; C26H28FNO; HMS643K19; 4-(4-fluorophenyl)-1,3,5-trimethyl-2,6-diphenylpiperidin-4-ol; STK700283; AKOS005607233; CCG-252194; MCULE-4096576995; SR-01000402777; SR-01000402777-1; 485754-59-4;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C26H28FNO",
"molecular_weight": "389.5",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "2729781",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01535"
]
},
{
"compound_ID": "D1211",
"name": "N-[(E)-1-[5-(4-Bromophenyl)furan-2-yl]-3-[3-(dimethylamino)propylamino]-3-oxoprop-1-en-2-yl]-4-methylbenzamide",
"synonyms": "ZINC1823666; N-[(E)-2-[5-(4-bromophenyl)-2-furyl]-1-({[3-(dimethylamino)propyl]amino}carbonyl)ethenyl]-4-methylbenzamide;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C26H28BrN3O3",
"molecular_weight": "510.4",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "1602555",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01536"
]
},
{
"compound_ID": "D1212",
"name": "(2Z)-3-{N-[4-(4-Chlorophenyl)phenyl]carbamoyl}prop-2-enoic acid",
"synonyms": "ZINC32116749; AKOS000513750; ST071030; AB00075525-01; (2Z)-3-{N-[4-(4-chlorophenyl)phenyl]carbamoyl}prop-2-enoic acid;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C16H12ClNO3",
"molecular_weight": "301.72",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "1675254",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01537"
]
},
{
"compound_ID": "D1213",
"name": "4-[(E)-3-(4-Ethylpiperazin-1-yl)prop-1-enyl]-N,N-dimethylaniline",
"synonyms": "Cambridge id 5424907; SCHEMBL15702607; ZINC19633596; AB00084930-01; SR-01000208781; SR-01000208781-1;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C17H27N3",
"molecular_weight": "273.4",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "782860",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01538"
]
},
{
"compound_ID": "D1214",
"name": "1,5-Dihydro-4,5-diphenyl-2H-imidazol-2-one",
"synonyms": "4,5-diphenyl-1H-imidazol-2(5H)-one; 53684-56-3; 1,5-Dihydro-4,5-diphenyl-2H-imidazol-2-one; 4,5-diphenyl-1,5-dihydroimidazol-2-one; 4,5-DIPHENYL-3-IMIDAZOLIN-2-ONE; 39311-14-3; 4,5-Diphenyl-2-imidazolinone; NSC1152; EINECS 258-701-4; Maybridge1_000016; Cambridge id 5162292; MixCom1_000016; Oprea1_012589; Oprea1_172610; CBDivE_015965; MLS000105549; CHEMBL1529823; CTK4J8609; CHEBI:105232; HMS2411K17; NSC-1152; NSC27031; CCG-41050; NSC-27031; STK326521; AKOS000733023; AKOS016043527; MCULE-4317582684; ACM39311143; SMR000102430; ST003030; 4,5-Di(phenyl)-1,5-dihydroimidazol-2-one; 4,5-diphenyl-1,5-dihydro-2H-imidazol-2-one; 2H-Imidazol-2-one,1,5-dihydro-4,5-diphenyl-; AB00074753-01; SR-01000631152-1; BRD-A14964391-001-10-4; Q27182941;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C15H12N2O",
"molecular_weight": "236.27",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "95311",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01539"
]
},
{
"compound_ID": "D1215",
"name": "2-[(E)-2-(4-Chlorophenyl)ethenyl]-1-methyl-1H-benzimidazole",
"synonyms": "Cambridge id 5663561; CHEMBL226007; SCHEMBL8548385; YUIBZEGEDQMBFQ-DHZHZOJOSA-N; ZINC3877123; STL257585; AKOS002231935; ST50116200; 1-Methyl-2-(4-chloro-trans-styryl)-1H-benzoimidazole; 2-[(1E)-2-(4-chlorophenyl)vinyl]-1-methylbenzimidazole; 2-[(E)-2-(4-Chlorophenyl)ethenyl]-1-methyl-1H-benzimidazole; N-Methyl-2-(4-chlorophenyl)eth-2-en-2-yl-1H-benzimidazole; 2-[(E)-2-(4-Chlorophenyl)ethenyl]-1-methyl-1H-benzimidazole #; 259743-62-9;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C16H13ClN2",
"molecular_weight": "268.74",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "5377781",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01540"
]
},
{
"compound_ID": "D1216",
"name": "4-[1-Azabicyclo[2.2.2]octan-3-ylidene-[4-(dimethylamino)phenyl]methyl]-N,N-dimethylaniline;hydrochloride",
"synonyms": "Status: 404; Code: PUGREST.NotFound; Message: No synonyms found for the given CID(s);",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C24H32ClN3",
"molecular_weight": "398",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "2831719",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01541"
]
},
{
"compound_ID": "D1217",
"name": "4-Oxo-4-((4-(styryl)phenyl)amino)but-2-enoic acid",
"synonyms": "328540-82-5; 3-(4-Styryl-phenylcarbamoyl)-acrylic acid; 4-Oxo-4-((4-(styryl)phenyl)amino)but-2-enoic acid; SCHEMBL13381360; ZINC177289; AKOS001610109; BB 0221177; AB00076502-01; (2E)-3-({4-[(E)-2-phenylethenyl]phenyl}carbamoyl)prop-2-enoic acid; (2E)-4-oxo-4-({4-[(E)-2-phenylvinyl]phenyl}amino)but-2-enoic acid;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C18H15NO3",
"molecular_weight": "293.3",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "5399557",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01542"
]
},
{
"compound_ID": "D1218",
"name": "2,5-Dianilinoterephthalic acid",
"synonyms": "2,5-Dianilinoterephthalic acid; 10109-95-2; 2,5-bis(phenylamino)terephthalic acid; 1,4-Benzenedicarboxylic acid, 2,5-bis(phenylamino)-; W-110248; CBDivE_010595; EINECS 233-302-8; EC 233-302-8; Oprea1_567229; Oprea1_594854; 2,5dianilinoterephthalic acid; SCHEMBL351705; 2,5 -dianilinoterephthalic acid; 2,5-dianilino-terephthalic acid; DTXSID7064948; CTK0I1085; ZJQZWNLKRBUEKX-UHFFFAOYSA-N; 2,5-diphenylaminoterephthalic acid; ZINC758690; 2,5-di(phenylamino)terephthalic acid; 2,5-di(phenylamino) terephthalic acid; MCULE-7797817338; FT-0636630; C-49840; 1,4-Benzenedicarboxylicacid, 2,5-bis(phenylamino)-;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C20H16N2O4",
"molecular_weight": "348.4",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "82351",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01543"
]
},
{
"compound_ID": "D1219",
"name": "4-Methoxy-N-[4-(thiazol-2-ylsulfinamoyl)-phenyl]-benzamide",
"synonyms": "CBKinase1_000331; CBKinase1_012731; Oprea1_612419; Oprea1_790724; CBDivE_006862; SCHEMBL13212143; 4-Methoxy-N-[4-(thiazol-2-ylsulfinamoyl)-phenyl]-benzamide; STL331198; AKOS000536676; MCULE-9203124173; EU-0035359; ST50182154; AB00074516-01; SR-01000404524; SR-01000404524-1; 4-methoxy-N-{4-[(1,3-thiazol-2-ylamino)sulfinyl]phenyl}benzamide; (4-methoxyphenyl)-N-{4-[(1,3-thiazol-2-ylamino)sulfinyl]phenyl}carboxamide; 303796-29-4;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C17H15N3O3S2",
"molecular_weight": "373.5",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "987790",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01544"
]
},
{
"compound_ID": "D1220",
"name": "3-[(3,4-Dimethylphenyl)sulfonyl]propanenitrile",
"synonyms": "3-[(3,4-Dimethylphenyl)sulfonyl]propanenitrile; 313534-70-2; Cambridge id 5210670; Oprea1_819446; HMS1577F12; ZINC2030432; AKOS002666297; MCULE-2582488427; 2-[(3,4-dimethylphenyl)sulfonyl]ethyl cyanide; EN300-235860; L-3047; AB00075209-01; SR-01000389198; SR-01000389198-1; F0347-0105;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C11H13NO2S",
"molecular_weight": "223.29",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "1714889",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01545"
]
},
{
"compound_ID": "D1221",
"name": "4-[4-(1,3-Benzoxazol-2-yl)anilino]-4-oxobutanoic acid",
"synonyms": "CBKinase1_000108; CBKinase1_012508; Oprea1_010280; Oprea1_575000; CBDivE_010893; SCHEMBL15702608; ZINC2473187; AKOS000638306; MCULE-3279385485; AB00075795-01; BRD-K20763024-001-01-4;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C17H14N2O4",
"molecular_weight": "310.3",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "2054851",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01546"
]
},
{
"compound_ID": "D1222",
"name": "1-(3-Chlorophenyl)-2,3,4,5,6,7,8,8a-octahydro-1H-isoquinolin-4a-ol;hydrochloride",
"synonyms": "MCULE-2190953663;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C15H21Cl2NO",
"molecular_weight": "302.2",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "2828615",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01547"
]
},
{
"compound_ID": "D1223",
"name": "6-Methyl-2-(1,2,2,2-tetrafluoroethyl)-1H-benzimidazole",
"synonyms": "41185-76-6; 6-methyl-2-(1,2,2,2-tetrafluoroethyl)-1H-benzimidazole; CBDivE_010955; MLS000711103; CHEMBL1537082; DTXSID10385214; 1H-Benzimidazole, 6-methyl-2-(1,2,2,2-tetrafluoroethyl)-; HMS2629E23; AKOS000505505; MCULE-5158659643; SMR000280870; AB00074157-01; 6-methyl-2-(1,2,2,2-tetrafluoroethyl)-1H-1,3-benzodiazole;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C10H8F4N2",
"molecular_weight": "232.18",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "2828769",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01548"
]
},
{
"compound_ID": "D1224",
"name": "Ethyl 6-amino-5-cyano-2-methyl-4-(2-nitrophenyl)-4H-pyran-3-carboxylate",
"synonyms": "ethyl 6-amino-5-cyano-2-methyl-4-(2-nitrophenyl)-4H-pyran-3-carboxylate; Oprea1_672599; RSCBB000230; STK725700; AKOS000558197; AKOS021988145; MCULE-1829228796; ST003353; AG-205/33677015; SR-01000423362; SR-01000423362-1; 5-ethoxycarbonyl-2-amino-4-(2-nitrophenyl)-3-cyano-6-methyl-4h-pyran; ethyl 6-amino-5-cyano-4-{2-nitrophenyl}-2-methyl-4H-pyran-3-carboxylate; 6-Amino-5-cyano-2-methyl-4-(2-nitro-phenyl)-4H-pyran-3-carboxylic acid ethyl est; 72568-53-7;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C16H15N3O5",
"molecular_weight": "329.31",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "2831068",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01549"
]
},
{
"compound_ID": "D1225",
"name": "N-(2,1,3-Benzoxadiazol-4-yl)-2,2,2-trifluoroacetamide",
"synonyms": "AB00074547-01; SR-01000197027; SR-01000197027-1;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C8H4F3N3O2",
"molecular_weight": "231.13",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "786739",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01550"
]
},
{
"compound_ID": "D1226",
"name": "4-Tert-butyl-N-(4-methylphenyl)benzamide",
"synonyms": "4-tert-butyl-N-(4-methylphenyl)benzamide; CBDivE_005421; Cambridge id 5210384; SCHEMBL7293746; ZINC3548020; STK249530; AKOS001304543; 4-t-butyl-N-(4-methylphenyl)benzamide; MCULE-3700951101; 129488-48-8; ST014472; [4-(tert-butyl)phenyl]-N-(4-methylphenyl)carboxamide; Z28134715;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C18H21NO",
"molecular_weight": "267.4",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "2664830",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01551"
]
},
{
"compound_ID": "D1227",
"name": "2-Methoxy-4-(morpholin-4-ylmethyl)phenol",
"synonyms": "2-methoxy-4-(morpholin-4-ylmethyl)phenol; Phenol, 2-methoxy-4-(4-morpholinylmethyl)-; Cambridge id 5423875; Oprea1_527353; SCHEMBL4145433; CHEMBL4098955; LQPYUEFSYJQQPL-UHFFFAOYSA-N; HMS1581N09; ZINC19633326; 2-methoxy-4-(morpholinomethyl)phenol; AKOS021294013; MCULE-9336431378; 415928-53-9; AB00084855-01; SR-01000208713; SR-01000208713-1;",
"trade_name": "",
"abbrev_name": "",
"description": "",
"molecular_formula": "C12H17NO3",
"molecular_weight": "223.27",
"state": "",
"clearance": "",
"volume_of_distribution": "",
"route_of_elimination": "",
"protein_binding": "",
"half_life": "",
"absorption": "",
"cid": "782723",
"classification": "Others",
"indications": "",
"side_effects": "",
"atc_codes": "",
"group": "Compound",
"drug_type": "",
"target": [
"T181"
],
"function": [
"F02110103"
],
"references": [
"RC01552"
]
}
]
}
